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INTRODUCTION 
The chemotherapy and chemoprophyllaxis of parasitic disease 
in farm animals ranks among the more important aspects of Veter- 
inary Pharmacology, owing to its close connexions with the 
economics of agriculture. 
The number and variety of veterinary specific chemothera- 
peutic agents at present in use in the field is very large indeed. 
Most of the chemotherapeutic substances have systemic actions end 
toxicity which often limit their usefulness and among the most 
pha.macodynamically active compounds in use in veterinary Chemo- 
therapy is quinuronium sulphate. Until recent years this drug 
was unrivalled in treating British Babesiasis. 
Babesiasis (piroplasmosis) is a disease of animals which has 
world-wide distribution. The parasite is an intra-erythrocytic 
protozoan which is transmitted from host to host by a species of 
tick. In the Continent of Europe the disease is found in cattle, 
sheep, horses and dogs, but in the British Isles it is only the 
bovine form which is recognised, and produces severe economic 
losses among affected herds. 
The signs and symptoms of disease are similar in all species 
and include cachexia fever, anaemia, jaundice and haemoglobinuria. 
This last named condition has given rise to the common names for 
the disease, namely British Redwater or Bovine Haemoglobinuria. 
The advent of practical chemotherapy in the early 1930s 
brought considerable interest in the action of chemical agents 
against/ 
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against certain protozoal infections of economic importance (The 
history of the development of arsenical and antimonial chemo- 
therapy of trypanosomiasis is well-known). Veterinary research 
workers at this time were anxious to find a cure for babesiasis 
and not unnaturally many of the early trypanocidal agents were 
tried with only minor success, (Sergent, Donatein, Parrot and 
Lestovard 1933). It was not until 1935 that quinuronium 
sulphate was made available (Cernaisnu, Schuldner and Magureanu, 
1935) and this compound remained the principal piroplasmocidal 
agent for thirty years under various trade names such as i\kiron, 
Acapron, Acaprin, Babesan, and Pirevan (Smythe (i), 1935). 
From its discovery in 1935 the therapeutic use of quinuronium 
was always accompanied by severe toxic side-effects, and the litera- 
ture makes numerous mentions of these and the fact that a con- 
current subcutaneous injection of aarenaline hydrochloride did 
much to alleviate untoward symptoms. Despite this, fatalities 
were not uncommon especially in animals severely parasitised and 
srossly anaemic* Nevertheless quinuronium gained in popularity 
very rapidly indeed and in Britain the compound was described as 
superior to any agent so far used in the treatment of British Red- 
water (Smythe (ii), 1935). Among the numerous accounts of 
successful therapy in all domesticated species was the first 
accurate account of the toxic signs and symptoms in sheep 
(Cernaianu, Schuldner and Magureanu, 1935). These workers 
described an initial restlessness which was closely followed by 
salivation, micturition and defaecation. The more severely 
affected/ 
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affected animals were seen to have generalised muscular spasm, and 
difficulty with respiration and a few animals would collapse and 
die. A further interesting point which arose in this study was 
that if the some sheep were given a second injection of quinu-. 
ronium within about two weeks of the firsts many more animals 
showed severe toxic signs and the mortality rate was higher than 
previously. This paper was the first to ascribe toxicity to 
cholinergie stimulation as such, but no reason was suggested by 
these workers for the apparent hyper-susceptibility to a second 
dose. 
A somewhat different approach was made by Kikuth (1935) who 
drew attention to the resemblance between quinuronium poisoning 
and shock, but did not investigate this possibility. 
As far as can be ascertained no precise pharmacodynamic study 
was made on quinuronium until 1959 (Kronfeld, 1959) when a detailed 
study in cats and rata revealed what was described as a "respiratory- 
type" death. Kronfeld reported a rise in carotid blood pressure 
in the cat and irregular dyspnoeic breathing. Respirations 
always ceased several minutes before the heart finally stopped. 
In unanaesthetised rats quinuronium produced a constant character- 
istic response, namely "excitement", coughing and face-washing 
movements. Gasping respirations and jumping movements ensued, 
ending in convulsion and death with cyanosis of the visible 
extremities and bulging eyes. The author ascribes this picture 
to anoxic excitation. No sympathomimetic amine was in any way 
useful in delaying or preventing death (adrenaline, ephedrine, and 
amphetamine/ 
amphetamine were tried). It seemed to Kronfeld that para- 
sympathetic activity was but a transient phase and not the cause 
of death. He went on to show that quinuronium did in fact depress 
cellular oxygen uptake in liver and brain slices and homogenates. 
In 1961 Runnier and Laue gave evidence of protection of sheep 
from severe quinuronium toxicity by the use of atropine (1 mgm/ 
kilo). This is supported by the present work. However, Runnier 
and Laue also used 2.P.A.M. (pyridine 2-aldoxime methiodide) which 
is allegedly specific for poisoning by organophosphorus compounds. 
Rummler and Laue showed that quinuronium would reduce the cir- 
culating levels of cholinesterase in a proportion of dogs and sheep. 
But in other experiments designed to demonstrate enzyme-protection 
by pyridine 2-aldoxime methiodide (2.P.A.M. )0 these authors did 
not estimate the cholinesterase activity after premedication with 
2.P.L.M. Their assessment of the value of this antagonist in 
protecting sheep from the effects of quinuronium poisoning was 
based solely on clinical observations. The results were moon- 
elusive. 
Some of the pharmaceutical companies marketing quinuronium 
have ascribed the toxicity of their product to "breakdown" sub- 
stances from killed babesia parasites and disrupted r.b.o.s. 
There is doubtless some truth in this as was shown by Goodwin and 
Richards (1960), who described pharmacologically active compounds 
in the blood of rodents infected with Babesia Rhodaini. Although 
such compounds may be important in the symptomatology of the disease, 
they probably play only a minor role on the toxicity of quinu- 
ronium since all the toxic signs described can readily be 
demonstrated/ 
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demonstrated in normal unparasitised animals. 
The constant search for a new babesicide with a better thera- 
peutic index than quinuronium achieved some success in the early 
1940's when a number of diamino phenyl-urea derivatives were 
synthesised (Gerchuk, 1941). These compounds did not differ 
greatly from quinuronium in respect of toxicity (Petrova, 1955). 
However, another substituted urea (amicarbalide) was produced, 
whose L.D.50. was some ten times greater than that of quinuronium. 
The efficacy of the new compound in field trials has secured its 
success and the only reported toxicity has been local oedema at 
the site of injection and some transient dullness and ataxia at 
the highest dose range (Ashley, Berg and Lucas, 1960) and 
(Beveridge, Thwaite and 6hepherd, 1960) . 
Despite the introduction of amicarbalide quinuronium still 
finds favour because of its cheapness and high degree of efficacy 
in all forms of babesiasis, but its degree of toxicity presents 
many problems during clinical use. 
The pharmacodynamie activity of quinuronium and the comparison 
with amicarbalide have thus, so far as can be ascertained, 
received little detailed study. Hence further investigation 
seemed to be important. 
The experiments described in this thesis were designed to 
investigate the pharmacodynamie activity of quinuronium and 
amicarbalide, especially with regard to cholinergie activity and 
the release of histamine. 
STRUCTURE OF UINUROI\1IUM SUPHT 
6:6' URILENE - BIS (I METHYL QUINOLINIUM) 
BI -IETrisuLPH1TE. 
o 
It 
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2CH3SO4 
This compound is a simple substituted urea. It is a yellow 
amorphous powder stable at room temperature and readily soluble in 
water to metro a neutral, stable solution. 
STRUCTURE OF ANICARfALIDE ISETHIONATE 
3:3' DIAt-íZNO - Cr.TtBF.IV:[T.,IDE DIISETHIOïvTATE. 
HNÇ 
NH2 H2N 
2HO.CH2.CH2.SO3H 
This substance is a modification of the substituted urea. 
It is a white amorphous powder stable at room temperature and 
soluble in water to produce a neutral stable solution. 
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SECTIONI 
THE INVESTIGATION OF PHAREACODYEAMIC ACTIVITY 
Animals poisoned with quinuronium always show marked dyspnoea 
and many individuals stagger and sometimes collapse showing 
dilated pupils, pale mucous membranes and weak pulse. Techniques 
were therefore considered for the investigation of the cardio- 
vascular and respiratory activity of quinuronium. 
METHOD'S. 
1. CAROTID BLOOD PRESSURE AND RESPIRATION 
(a) Rat. 
Adult albino rats were anaesthetised with urethane and set 
up in the usual way for the recording of blood pressure kymo- 
graphically by means of a Condon Rat Blood pressure manometer. 
(b) Guinea ri, Chicken and Rabbit. 
Adult animals were anaesthetised with urethane and blood 
pressure was recorded kymokTaphically with a mercury manometer. 
(0) Sheep. 
Adult south country cheviot sheep were anaesthetised with 
intravenous thiopentone sodium and maintained throughout the 
experiment on closed circuit cyclopropane and oxygen. Blood 
pressure was recorded kymouaphically with a mercury manometer 
and simultaneously a respiratory recording was made from the 
tracheal cannula by means of a bellows recorder. 
9. 
12 were dissolved in isotonic saline and injected intraven- 
ously. Acetylcholine chlorides adrenaline chloride and 
histamine acid-phosphate were injected in order to show the 
effects of known compounds upon the carotid blood pressure in 
the various species. Olinuronium and amicarbalide were both 
injected for the purposes of comparison. The antagonists used 
were atropine sulphate and mepyramine male ate for the purpose of 
demonstrating respectively antimuscarine and antihistamine effects. 
2. ACTIONS ON PERIPHERAL BLOOD VESSELS 
A. THE ISOLATED PERFUSED RABBIT EAR. 
Ears were taken from freshly killed rabbits and were either 
used immediately or after having been stored at 4°C overnight:- 
the drug responses being the same in each case. 
The method is essentially that described by Rischbeiter (1913) 
and involved a perfusion via the central artery of a rabbit's ear 
of oxygenated Krebs solution (Krebs and Henseleits 1932) . The 
total perfusate was passed through a photo-electric drop counting 
unit which recorded kymographically by means of Thorpe impulse 
counter. 
Drugs were dissolved in isotonic saline and injected into the 
perfusion fluid. 
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B. SMALL INTESTINE ANDTIND LIMB PLETHYSMOGRAPHY IN SHEEP. 
Plethysmography was carried out simultaneously with the 
recording or blood pressure and respiration in sheep. The methods 
are essentially those of Dale and Laidlaw.(1910) and Dale (1914.). 
Small Intestine. 
The abdomen of the sheep was opened on the right flank and 
a convenient loop of small intestine located. A segment of 
intestine some three or four inches in length was clamped at each 
end with bowel forceps and the ligated (producing i.e., a sausage- 
like isolated segment). The free cut ends of the remaining bowel 
were similarly ligated. The artery and vein supplying this 
isolated segment of bowel were cleared of mesentery and fat, and 
the segment was placed in an sir plethysmograph made of perspex. 
The vessels passed to the exterior through a small notch under the 
lid (Fig. P.1.) which was made sir tight with petroleum jelly. 
Hind Limb. 
With the sheep lying on its side the "upper" hind limb was 
taken and clipped free of wool and htlir over the whole leg. The 
limb was greased above the stifle joint and placed inside a hollow 
cylinder of perspex whose distal end was closed and whose proximal 
end carried a rubber sleeve which inverted into the perspex tube 
and gripped the upper limb sufficient to allow the plethysmograph 
to be filled with water: the whole cylinder now being both air 
and water tight (Fig. P.2.). The cylinder was fitted with a 
side-tube for recording changes in pressure. 
The gut and limb plethysmographs were connected by their 
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side-tubes through transducers (Greer manometers) to a pen- 
recording system. 
3. ISOLATED HEART OF RABBIT AND GUINEA FIG 
Heart organ-bath. 
The assembly is depicted in Figure C.A. and was described by 
Bartlet (1963). The apparatus was essentially a glass cannula 
fixed into the side of a perspex organ-bath. The heart coronary 
system was perfused via the aortic cannula with Krebs solution 
(Krebs and Henseleit, 1932) which had been filtered (Bleehan and 
Fisher, 1954) and gassed with 5/0 002 in oxygen. The coronary 
perfusate accumulated in the organ-bath and was also gassed by 
5/0 00 
2 
in oxygen. Thus the totally immersed heart was perfused 
through its coronary vessels and the perfusate measured by 
displacement from the bath into a photo-electric drop counter. 
The heart beat was recorded from the left ventricle by means 
of a thread which passed over a pulley to a spring loaded lever 
writing on a kymograph drum. 
Drugs (contained in a small volume of saline) were injected into 
the perfusion fluid by means of a small rubber injection chamber 
just prior to the heart cannula. 
Note. In the classical arrangement of the perfused isolated heart 
described by Langendorff (1895) severe cooling occurs especially as 
drug action modifies the coronary circulation. More recent 
methods (e.g. that described above) obviate this disadvantage. 
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THE ISOLATED SMOOTH MUSCLE OF THE LNTESTINE AND 
URINARY BLADDER 
Of the many clinical signs of quinuronium toxicity, 
micturition and defaecation are among the most Obvious. It was 
therefore proposed to investigate the pharmacodynamies of the 
smooth muscle of the intestine and urinary bladder. 
A. ISOLATED GUINEA PIG ILEUM. 
(a) GENERAL PHARMACOLOGY 
Small segments of terminal ileum were set up in the usual 
way in aerated Tyrode solution in an isolated organ-bath at 
52°C. 
Drugs. Acetylcholine, histamine, quinuroniumsamicarbalide, 
atropine and mepyramine were used. 
(b) THE TRENDFMNBURG PREPARATION 
On present evidence it was considered that useful information 
might be gained from testing the effect of cuinuronium and 
atropine on the peristaltic activity of the guinea pig ileum. 
For this purpose the method of Trendelenburg (1917) was employed. 
Drugs. Quinuronium (5 ug to 200 ug), carbachol (10 ug) and 
atropine (10 ug). 
B. ISOLATED BLADDER STRIPS. 
(a) Guinea Pis. 
Guinea pig bladders were bisected longitudinally and each 
3.5 
half set up in the usual way in an isolated organ-bath in 
oxygenated Tyrode solution at 55°O. 
(b) Sheep. 
Bladders from freshly killed sheep were cut open longitu- 
dinally, washed with isotonic saline and immersed in cold Tyrode. 
Longitudinal strips (measuring 0.5 cm by 4. ems) were made through 
the whole thickness of the bladder. The mucosa was carefully 
removed and also all extraneous serosal attachments and each 
strip was set up in an organ-bath at 55°0 in oxygenated Tyrode. 
5. GLANDULAR SLCRETION 
During quinuronium therapy, in &9 ition to signs of cardio- 
vascular collapse and stimulation of smooth muscle, there is 
invariably profuse salivation in affected animals. Methods for 
measuring this stimulation of salivary secretion were investigated. 
A. SECRETION OF PAROTID SALIVA. 
Sheep were anaesthetised with intravenous thiopentone and 
maintained on pentobarbitone. The area of the mandible was 
clipped of hair and the parotid salivary duct located through a 
skin incision made near the angle of the jaw; (the duct lies 
lateral to the external maxillary artery and vein). The 
salivary duct was cannulated with fine bore polythene tubing. 
After a space of several minutes, saliva began to flow and 
was passed through a photo-electric drop recorder connected to a 
14* 
Thorpe impulse counter. Simultaneously, carotid blood pressure 
was recorded kymographically by means of a mercury manometer. 
B. SECRETION OF GASTRIC ACID IN THE ANAESTHETISED RAT. 
It was considered possible that the stimulation of salivary 
secretion by quinuronium might indicate more generalised activity 
on glandular secretion. Methods for investigating the effects 
on gastric hydrochloric acid secretion were considered: 
Two strains of adult rats were used: brown-hooded and 
albino. Both sexes were employed in a random fashion. 
The technique used was a simple modification of that 
described by Ghosh and Schild (1958). 
All animals were anaesthetised with 29% w/v urethane at the 
rate of 0.7 ml per 100 n. The trachea was cannulated and the 
pylorus of the stomach located through a midline incision behind 
the xyphisternum. A longitudinal incision was made in the 
duodenum near the pylorus and the end (a) of a glass tube of 
mm diameter inserted and passed via the pylorus into the stomach 
and secured firmly by ligating the duodenum, carefully avoiding 
blood vessels (Fig. G.1.). The duodenal cannula (as shown) was 
clamped so that the 'U' bend (c) was inverted. This arrangement 
created a small back pressure into the stomach which maintained 
a slight degree of distension in the organ. This was found to 
be advantageous in stimulating a steady 'control secretion of 
acid. 
A polythene tube of 1.5 mm diameter and 15 cm long was passed 
via the mouth down the oesophagus and into the stomach. Its tip 
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could be palpated with a finger in the abdomenal incision. nhen 
the tip of the tube had passed the cardiac sphincter, the cannula 
was secured by ligating the oesophagus. This oesophageal cannula 
was connected to an aspirator bottle of normal saline placed 
above the rat so that saline could flow through a water bath at 
4.000 to the stomach, (Fig. G.2.). 
A steady flow of saline through the stomach was initiated 
and the organ gently palpated to dislodge and wash out food 
particles. By regulating a screw-clip on the saline reservoir a 
duodenal outflow of 0.5 cm to 1.0 ml per minute was established. 
This ensured that in each collection period the stomach volume 
had been cleared at least once. 
Acid Estimation. Samples of stomach perfusate were collected 
over each ten minute period and iffmediately titrated against 
N/100 NaOH using methyl-red as an indicator. 
Acid outflow was expressed as mis. N/100 NaOH required to 
neutralise each sample, or in terms of the equivalent in mis. 
N/100 Ha. 
Pre-treatment samples were taken until three consecutive 
ten minute readings were approximately equal (arbitrarily within 
10,X, of each other). 
Results were plotted as histograms using acid as ordinate and 
time abscissa. 
Drugs were administered via a cannula in the jugular vein and 
each compound was given over a period of five to ten minutes in 
small increments every minute, washed in with 0.1 ml normal saline: 
histamine acid phosphate; acetylcholine hydrochloride; compound 
16. 
48/60; neostigmine hydrobromide; quinuronium sulphate; 
amicsrbalide isethionate; atropine sulphate; menyramine meleate. 
The concentration of histamine is expressed in terms of 
base whereas all other compounds are given as their respective 
salts. 
NEUROMUSCULAR TRANSMISSION 
The methods employed so far have investigated the cholinergie 
effects of quinuronium in respect of parasympathetic (muscarinic) 
activity. Cholinergie substances including anticholinesterases, 
possess in addition to "musearinie" actions certain "nicotinic" 
effects, and techniques for examining one of these (namely events 
at the skeletal neuromuscular junction) were now considered, 
A. IN VITRO TECBNIQUES. 
CHICK BIVENTER CERVICIS MUSCLE 
Ginsborg and Werriner (1960) developed a method using the 
posterior belly of the chicken biventer eervicis muscle. The 
presenttechnique is exactly as described by Ginsborg and Warriner 
(1960) and the electrode assembly is depicted in Fig. NMI. 
Drugs. (0ainuronium sulphate; acetylcholine chloride; eserine 
salicylate; d-tubocurarine chloride; suxamethonium chloride. 
These were administered in not more than 0.2 ml normal saline and 
allowed to act for ten minutes or to maximum effect (whichever was 
shorter). Recovery was allowed over thirty minutes or to control 
(whichever was shorter). 
17. 
B. IN VIVO TECHEI(UEB. 
INTRODUCTION 
A method was required which would enable one to use a muscle 
(or muscles) with intact blood supply and attached normally to the 
bony skeleton in an animal under anaesthetic. 
The method of recording contractions of the anterior tibial 
muscle in the anaesthetised cat described by Brown (1938) is well 
known and the following description bears some similarity in 
principle to this method. 
(a) TAIE DIGITAL EXTENSOR MUSCLE GROUP OF THE CHICKEN PELVIC LBO. 
The anatomical description is given by Chamberlain (1943). 
By reference to Figs. IM 2, 3 and 40 the anatomical set -up can be 
seen. Fig. NM2 shows diagrammatically the musculature of the 
anterior aspect of the chicken hind liMb. The two muscles 
involved are the tibialis anterior and the extensor digitus lengus 
which both arise on the tibio- fibula between the lateral head of 
the gastrocnemius and medially the peroneus longes muscle. 
Fig. NM3 shows the lateral aspect of the right pelvic limb of the 
chicken with the skin removed, (Chamberlain, 1943). The anterior 
tibial muscle is inserted into the proximal end of the metatarsus 
whereas the extensor digitus lengurus makes insertions into each of 
the three main digits. Both muscles flex the tibiotarscl joint 
but only the long extensor extends the digits proper. 
The bulk of the biceps femoris muscle (Fig. NM3) was carefully 
ligated at its insertion near the femoro- tibial joint; cut and 
freed (point A); (Fig. Pub.). The body of the biceps muscle was 
carefully reflected (removing fascia) as far up towards the pelvis 
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as possible. The muscle was then cut across near to the pelvis 
and its body completely removed, Bleeding points were picked 
up with artery forceps and tied off individually, as it was 
virtmily impossible to apply an efficient mass ligature on so 
little residual tissue. The complete removal of the biceps 
femoris greatly facilitated the following procedures. With a 
small muscle retractor, the bodies of the semi-membranosus and 
semi-tendinosus muscles were withdrawn posteriorly as shown in 
Fig. 1114. This procedure clearly revealed the hypogastric 
artery, the femoral vein and the sciatic nerve which were seen 
lying on the "floor" of the cavity created by the removal of the 
biceps muscle. 
2-The sciatic nerve lies in the most posterior position in 
this cavity and divides before reaching the femorotibial joint 
into three branches, the most aaterior of which is the nerve trunk 
which supplies the digital extensor muscles. Lying close to this 
is the main hypogastric artery which supplies all the lower limb. 
From the main artery arise numerous branches. One of these is a 
large cutaneous vessel shown in Fig. El* and another is the 
gastrocnexnius artery which arises near the femorotibial joint. 
Either vessel is suitable for giving close arterial injections 
into the hypogastric trunk and may be cannulated with 1 mm 
diameter polythene tubing or alternatively a small size (sawn off) 
intravenous needle. These cannula may then be connected to a 
1 ml all glass "tuberculin" syringe by means of flexible tubing, 
for the purpose of giving intra-arterial injections...7 
The anterior branch of the sciatic nerve was freed of fascia 
19. 
and the electrode passed underneath. [The electrode comprised 
two silver wires which were curved in a half circle and set in 
perspex or other insulating materialj when the artery was 
cannulated and the electrode fixed in position under the nerve 
the "muscle cavity" was filled with medicinal paraffin and the skin 
closed over the site. 
In order to free the movement of the tibiotarsal joint all 
muscle tendon attachments were severed save those of the tibialis 
and long extensor. Basically this amounted to "ham-stringing" 
the limb. 
All this completed and the animal lying on its side, the limb 
was fixed rigidly in a semi-extended position by the use of intra- 
medullary surgical pins A. and B. , which passed respectively 
through the femorotibial and the region of the tibiotarsal joints 
( shown in Figs. NMI+. and NM5): pin B. avoided the actual joint in 
order to allow the free movement of the latter. Both pins I,. and 
B. were clamped above the limb and their pointed lower ends passed 
into the soft wood of the base board. 
A strong linen thread was attached to the foot near the small 
digit and the thread passed over a pulley to an isometric "spring" 
lever which inscribed on a smoked kymograph drum, (Fig. NM5). 
The "kick" of the limb was in a forward direction and so a 
third pin - C.- was driven into the base board behind the limb 
and acted as a "stop" for the resting limb, i.e. provided a firm 
and constant base line for the kymograph tracing. 
Stimuli were supra-maximal from a 'Telmer" Student-Class 
stimulator at a rate of 12 short rectangular wave impulses per 
20. 
minute. 
In addition to this procedure, the blood pressure of the 
animal was taken from the carotid artery and recorded kymo- 
graphically via a mercury manometer. 
Simultaneously, respiratory movements were recorded from a 
tracheal cannula connected with a writing bellows recorder. 
Also a jugular intravenous cannula enabled drug-sulutions to 
be injected by the alternative route. 
Drugs, Quinuronium sulphate; acetylcholine chloride; 
d-tubocurarine chloride. These were injected in a maximum of 
0.2 ml normal saline and allowed to act for ten minutes. 
Recovery was indicated by a return to normal, or after thirty 
minutes, whichever was shorter, 
(b) TEE DIGITAL EXTLNSOR YU-SOLE GROUP OF ThE RABBIT BIND L1MB. 
This experiment involved similar techniques to those 
described above for the chicken, Adult rabbits of approximately 
3 kilo weight were anaesthetised with urethane and the neuro- 
muscular preparation made as described for the chicken. 
Respiratory movements were recorded by a thread attached to 
the rib-cage, connected via a pulley wheel system to a spring 
loaded lever. 
LEag.sL. Quinuronium sulphate; d-tubocurarine chloride, 
suxamethonium chloride. 
RESULTS. 
21. 
C.AROTID BLOOD PRESSURE .AND RESPIRATION 
(a) Rat. 
Acetylcholine (0.2 to 1.0 ug) invariably produced hypotension 
(Dale, 1914) and adrenaline (0.5 ug) typically produced a rise in 
blood pressure. It was noticable that histamine (0.5 to 1.0 ug) 
produced a variable effect. Of the five rats recorded, histamine 
Showed a pressor response in two, and a depressor response in 
three animals. Quinuronium (2 to 10 ug) always had the same 
effect as histamine whether pressor or depressor. ktropine 
sulphate (500 ug) reversed the hypotensive effects of acetyl- 
choline (Figs. HP. 1 de 2) and of quinuronium. However, mepy- 
ramine maleate (200 ug) complete:I,/ blocked the action of both 
histamine and quinuronium (Fig. HP 3). Amicarbalide had no 
measurable effect on carotid blood pressure in this species. 
(b) Chicken, Guinea Pig and Rabbit. 
In these species quinuronium always produced a fall in blood 
pressure which could not be modified significantly by either 
atropine or mepyramine in the case of guinea pig and chicken; but 
in the rabbit, atropine afforded some protection. 
(e) 
In sheep, acetylcholine (50 to 100 ug), histamine (75 to 
100 ug) and quinuronium (50 ug to 50 mgm) produced falls in blood 
pressure, whereas adrenaline (20 ug) was typically pressor through- 
out the experiments. 
In Figures BP ¿f (a) and (b) it can be seen also that 
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FIG. Bk 4 (a) 
CAROTID BLOOD PRESSURE OF SHEEP. Ad. = ADRENAIUTE 
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22. 
quinuronium produced a reduction both in rate and amplitude of 
respiration. A therapeutic dose of quinuronium (10 to 30 mgm) 
reduced the tidal volume by 5 nd larger doses (e.g. 50 mg170 
produced temporary cessation of respiratory activity. 
Atropine (1 mgm per kilo) effectively blocked the action of 
quinuronium up to a dose of 20 to 30 mgm (1 to 1.5 mgm per kilo) 
but failed to protect sheep from death following an intravenous 
dose of 50 mgm quinuronium is BP 4 a.). Mepyramine blocked the 
depressor effect of histamine and antagonised quinuronium up to 
10 mgm (see Fig. BP 4 b.). A 30 mgm dose of quinuronium was much 
reduced in its action, whereas 50 mgm of quinuronium on the first 
injection produced prolonged hypotension and a second 50 mu 
killed the sheep. 
Atropine and mepyrarnine did not modify the effect of quinu- 
ronium on respiration. 
Amicarbalide had no effect on the blood pressure of the sheep. 
2, ACTIONS ON PERIPHERAL BLOOD VESSELS 
A. THE ISOLATED PERFUSED RABBIT EAR. 
Adrenaline (0.25 ug), acetylcholine (10 ug), histamine 
(10 ug) and quinuronium (1 mgm) were approximately equally 
vasoconstrictor, (Figs P3 a. & b. and P4); however, quinuronium 
had a much more prolonged effect than any other agent used. 
After atropinisation of the ear (1 mgm) acetylcholine failed to 
show a response, whereas quinuronium continued to cause vaso- 
constriction for some time, but over a period of approximately 
two hours the response to quinuronium gradually diminished but 
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23. 
was never completely abolished. In another experiment mepyramine 
was injected (1 man) and this failed to show any antagonistic 
effect on the action of auinuronium (Fig. P5). In each experi- 
ment, adrenaline produced the same effect throughout. 
2micarbalide failed to elicit any response in the ear, but 
after amicarbalide (Fig. P4) quinuronium and acetylcholine failed 
to show responses. 
B. SKIL INTESTINE iND HIND LIMB PLETHY6MOGR;IPHY IN SHEEP. 
(i) Gut. 
Acetylcholine (50 ug), adrenaline (25 ug) and histamine 
(50 ug) all produced a distinct but transient constriction in the 
vascular volume of the bowel segment. Quinuronium (100 ug to 
10 mgm) tended to produce very slight and sometimes prolonged 
dilation of the vascular bed of the bowel, which remained 
unaffected after mepyramine (25 men), Atropine (10 mgm) on 
the other hand, tended to abolish the quinuronium response, (see 
Fig. P6). 
(ii) Limb. 
Acetylcholine (50 ug) produced slight vasoconstriction of 
short duration followed by a marked vasodilation. This effect was 
simulated by quinuronium (100 ug to 10 mgm) which also showed 
slight initial constriction followed by slight dilation and 
increase in pulse volume. Histamine (50 ug) produced a vaso- 
constriction in the limb and decreased pulse volume; whereas 
adrenaline showed strong vasodilation and increased pulse volume. 
Mepyramine (25 mgm) caused abolition of quinuronium vasodilation 
VASCULAR CHANGES IN THE SMALL INTESTINE 
AND HIND LIMB OF THE SHEEP 
intestine./ \ ti"- ---r v 
limb MO" 
CONTRO LS 
P"bosAANI" *,11114S1i ,«NJ 444000. 
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24. 
in the low dose range, however 10 pgm quinuronium still produced 
a vasoconstriction. Mepyramine (25 rngm) followed by atropine 
(10 mgm) abolished all vaso- activity of quinuronium up to and 
including a dose of 10 ange (Fig. P6). 
3. ISOLATED BEr'art`i OF RABBIT AND GUINEA PIG 
(i) Rabbit Heart. 
Acetylcholine (1 ug) produced a typical reduction in rate 
and amplitude of the beating heart. Adrenaline (1 to 5 ug), 
noradrenaline (1 to 5 ug), histamine (10 to 50 ug) and quinu- 
ronium (100 to 500 ug) increased the amplitude of contraction, 
see Table 0.1. and Figs. Cl & 020 i.micarbalide was without 
effect. 
Effect of antagonists. The doses of agonist compounds were 
adjusted to produce approximately equal responses. 
Atropine (1 mgn) itself tended to depress the amplitude of 
contraction of the heart. It was thus difficult to assess the 
degree of change in amplitude. This was however measured as 
the percentage change in amplitude of contraction. Atropine did 
not alter the increase in amplitude induced by quinuronium, 
although the effect of acetylcholine was abolished completely, 
(Table C.1.). 
Mepyramine (1 ngn) itself depressed the amplitude of the 
heart by 6011:1::, but did not modify the effect either of quinuronium 
or histamine (see Table C.1.). 
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(ii) Guinea Pig Heart. 
Histamine (10 ug) produced a transient depression followed by 
a strong increase in amplitude. Quinuronium (50 ug) increased 
the amplitude of contraction, whereas amicarbalide had no effect, 
see Fig. 03. 
Effect of antagonists. Atropine (200 ug) produced an increase in 
amplitude of contraction but failed to modify the "stimulant" 
effect of quinuronium. 
Mepyramine (200 ug) by itself depressed the amplitude of 
contraction by approximately 50% and failed to protect the heart 
from the effects of quinuronium, (Table C.2.) . 
4. THE ISOLATED SMOOTH MUSCLE OF THE INTESTINE AND 
URINARY BLADDER 
A. ISOLATED GUINEA PIG ILEUM. 
(a) GENERAL PHARMACOLOGY 
Acetylcholine and histamine produced strong contractions of 
the guinea pig ileum. Quinuronium produced increased spontaneous 
gut activity and usually increased the resting tone of the muscle. 
After riuinuronium the activity of acetylcholine was potentiated 
and the spontaneous activity of the organ became very marked; four 
to six changes of Tyrode being necessary to stabilise the prepara- 
tion. Amicarbalide did not show any noticable activity on the 
ileum, however after amicarbalide the activity of acetylcholine 
was slightly inhibited. 
Atropine abolished the actions of acetylcholine and quinu- 
ronium completely anddid not alter the response due to histamine. 
::'IG. 6.1. 
GUINEA PIG PERISTALSIS: TI-3'r, TREND&LPID,BURG 
PREPARATION OF GUINEA PIG II:EUNi. UP.PER. TRACING SHOViS 
LONGITUDINAL CONTRACTIONS A+iD LO'rtiE/ TRACING REPRESENTS 
CHANGES IN VOLUME. C = CONTROL RESPONSE; P=QUINU- 
ROIdIUM SULPHATE. 
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(b) THE TRENDELENBURG PREPARATION 
In Fig. Si, the upper tracing represents longitudinal 
contractions and the lower tracing changes in volume. Quinu- 
ronium (5 ug) did not influence the response, whereas doses of 
20 ug or more increased the tone of the gut segment. Volume 
changes were smaller and peristaltic rhythm slower under the 
influence of quinuronium. This effect was shown also by 
carbachol. 
Atropine abolished all reflex peristaltic activity in the 
ileum (Trendelenburg, 1917) and antagonised the effects of 
quinuronium and carbachol on peristaltic activity. 
B. ISOLATED BLADDER TRIPS. 
Guinea pig (Fig. S2) and sheep bladder muscle (Fig. S3) 
contracted strongly to acetylcholine and histamine. Quinu,- 
ronium had a variable effect either producing some longitudinal 
contraction or enhancing spontaneous movement of the muscle. 
In some specimens, quinuronium alone produced no observable effect. 
However, in all cases after application of quinuronium to the 
tissue the response produced by acetylcholine was markedly 
enhanced, whereas that due to histamine was unaltered. 
imicarbalide generally produced no observable effect on 
the bladder musculature, but in some sheep preparations the drug 
produced a small contraction. It was possible to demonstrate 
that amicarbalide inhibited slightly the action of acetylcholine 
without altering the response to histamine, .(see Figs. S2 and S3). 
 Atropine 1.10-7G. 
. . H50H20 . H30. . . H30 . H20 . . . H50. . H50 ' 
A5 A15 A30 A30 A15 A20 A10 A20 A20 A10 A20 A20 A50 
P1000 
H40 H50 
A40 A10 A 20 A 50 
H20 H50 H20 H40 
A100 A50 
AM AM 
1000 5000 
H = Histamine 
A .Acetylcholine 
P = Quinuronium 
AM = Amicarbalide 
DOSES = MICROGRMS. 
FIG. 5.2:. 
CONTRACTIONS OF THE SMOOTH MUSCLE OF 
GUINEA. PIG URINARY HGADDER. 
 Atropine 1x107G. 
_- y I _f -I 
H3.0 . . H3.0 H3.0 
A2.0 A1.0 AO.5 A0.5, A0.5 . A0.5 A01 40.4 A1.0 A0.5 . A2.0 450.0 
P1000 P5000 
A3 
, H10 
A5 , A10 AS A4 A2 
A M 2000 
P 5000 
H = HISTAMINE 
A = ACETYLCHOLINE 
P = QUINURONIUM 
AM = AMICARBALIDE 
DOSES = MICROGRMS. 
i1 s7 
SMOOTH MUSCLE CONTRACTIONS OF THE 
SHEEP URINARY BLADDER. 
27. 
5,....._GIANDULia SECRETION 
A. SECRETION OF PAROTID 6nLIVA IN SHEEP. 
Acetylcholine increased the flow of saliva and lowered the 
carotid blood pressure; but the effect was very transient, only 
lasting for one minute. A dose of histenine which was equi- 
active with acetylcholine in lowering the blood pressure had 
either a very small effect or produced no change in salivary 
flow. A hypertensive dose of adrenaline produced a distinct but 
transient increase in salivary secretion. Quinuronium in doses 
less than 1 nulproduced no change in salivation, whereas doses 
of 1 nigm to 5 mgm induced a large and prolonged increase in 
salivary flow. The initial very marked effect lasted between 
ten and fifteen minutes and then decreased slowly but did not 
return to the original (control) flow within forty-five minutes 
of the last injection of euinuronium. When doses of acetyl- 
choline were superimposed upon this steady phase of enhanced 
secretion, the activity of acetylcholine on both salivation ana 
blood pressure was potentiated, (See Fig. s.4 and Table S.1). 
Ìinicarbalide had no effect on salivation. 
The upper tracing on Fig. 6.4 indicates the flow of saliva as 
recorded by a Thorpe impulse counter working on a one minute cycle. 
Calibration of the drop counting device showed that each "step" 
on the tracing indicated 0.1 ml of saliva. On this basis the 
values shown in Table 5.1. were evolved. The figures therefore 
indicate the increase in mean salivary outflow per minute induced 
by intravenous drug injections. 
The sheep were injected with atropine (1.0 mgm per kilo), 
28. 
which did not reduce the rate of salivation to its initial 
resting (control) flow. Nevertheless atropine effectively 
blocked the action of both acetylcholine and quinanonium on 
blood pressure and salivary secretion, whereas the action of 
histamine on blood pressure remained unaffected. 
TABLE S.i. 
THE ACTION OF ADRENUIVE HISTAMINE ACETYLCHOLINE AND UINU- 
RONIUM ON THE BLOOD-PRESSURE AND SALIVATION OF SHEEP. 
DRUG DO6E 
INCREASE IN MEAN SALIVARY FLOW: 
(mls per minute) 
Drug 
Alone 
After 
Quinuronium 
After 
Atropine 
ADRENALINE 25 ug 0.35 - - 
HISTAMINE 40 ug 0.00 - 0.00 
60 ug 0.00 - 0.00 
ACETYLCHOLINE 10 ug - 0.51 - 
20 ug - 0.60 - 
40 ug 0.50 1.04 0.00 
150 ug - 0.00 
QUINURONIUM 250 ug 0.00 - - 
1.0 mgm 0.32 - - 
5.0 mgm 1.66 _ 0.00 
10.0 mgm - - 0.00 
cm 
Hg 
90mm 
cm 
Hg 
80mm 
a,r. 
,I 
r_ _ __:___, _ __ _ -r . r =_ _, . ._ . - _ : / ////// 
Ad Ac P P 
25ug 40ug 4Oug 60ug 250u9 I mg 
Ac Ac Ac 
4Oug 2Oug lOug 
P 
5 mg 
ATROPINE P P Ac Ac H H 
10 mg 5mg 10mg 4Oug 6Oug 60ug 4Oug 
SALIVARY FLOW 
BLOOD PRESSURE 
FIG. S.44.. 
SECRETION OF PAROTID SALIVA IN THE 
ANAESTHETISED SHREP. UPPER TRACING 
SHOWS RATE OF SALIVARY FLOW AND LOWER 
TRACING CAROTID BLOOD PRESSURE. 
AL= ADRENALINE; H. = HISTAMINE; 
AC. = ACETYLCHOLINE; P. = QUINURONIUM. 
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B. SECRETION OF GA.STRIC ACID IN THE RAT. 
Histamine (25 ug per min for 10 mins) and acetylcholine 
(10 ug per min) increased gastric acid secretion (Ghosh and 
Schild, 1958). Quinuronium (30 ug/Min) produced a marked and 
prolonged increase in acid secretion. However, if at the maximum 
rate of acid secretion by quinuronium, 2 mgm atropine was given 
intravenously the acid outflow was immediately reduced. A second 
dose of quinuronium given thirty minutes after atropine gave a 
distinct but markedly reduced acid output. Atropine inhibited 
the acetylcholine-induced acid secretion, but did not modify that 
stimulated by histamine, (see Fig. G3 a. ez b., and Table G.I.). 
Mepyramine did not antagonise gastric acid secretion induced 
by histamine, acetylcholine or quinuronium (Table G.2.). 
Neostigmine (20 ug per min for 10 mine) increased the 
gastric acid. outflow. Not only was neostigmine active in inducing 
gastric acid secretion, but the response to acetylcholine was 
potentiated after neostigmine (Table G.3.). Compound 44/80 
(20 ug per min for 10 mins) induced gastric acid secretion, 
(Table G.3.) but failed to potentiate acetylcholine induced 
secretion, whereas from Fig. G.4. it is clear that quinuronium 
produces a significant potentiation of acetylcholine. 
The effect of amicarbalide on gastric secretion was 
investigated. As can be seen in Table G.4. amicarbalide produced 
a small amount of gastric acid secretion. Neither mepyramine 
nor atropine showed any significant antagonism for this secretion. 
It was noted that after amicarbalide, the acid secretion induced 
by acetylcholine was greatly reduced (Table G.5.). 
Expmt^Ì 
RAT . 
N4 5 
mis 
N/100 
N a OH 
1.0 
0.9 . 
0.8 
0.7 
0.6 
0.5 
0.4 
0.3 _ 
0.2 
0.1 
.r 
Atrop i ne 
H 25rg 
min 
Ac10rg P3021 
man min 
Time/10min 
P30g 
min 
Ac10r2 H 251-ig 
min min 
PIG. G.3. (a). 
áEC:ftETION OF GASTRIC fiYl3ROCETLORIC ACID IN TEE 
ANAESTHETISED '  RAT INDUCED BY:- Ti = HIS ' ' iNE BASE; 
Ac = ACETYLCHOLINE CHMOR.IDE; P = ttiUINÜ'ONIÚ1i SULPHATE. 
( DRUGS M;tECTID EVERY :MINUTE OVER A TEN T,aNUT'ï: PERIOD) . 
ORDINATE = m15. N/100 ACID; Ai3SCISSA ! TIME. 
FIG. G.4. 
TOTAL INCREASE IN GASTRIC ACID SECRETION INDUCED 
BY ACETYLCHOLINE (Ac) BEFORE AND AFTER QUINELRONIUM 
(PIREVAN). 
ORDINATE = mls N/I00 ACID. 
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6. NEUROMUSCULAR TRANSMISSION 
IN VITRO - CHICK BIVENTER CERVICIS. 
Quinuronium (5 - 10 ug) produced a potentiation of the muscle 
twitch which was comparable with that induced by eserine (150 ug). 
It was noticeable with quinuronium that after the initial 
potentiation of the twitch amplitude there was a rapid return to 
normal or even reduced amplitude of contraction. With eserine 
the potentiation was maintained and the preparation was restored 
to normal only by washing. Large doses of quinuronium (1 to 
2 mgm) produced marked reduction in the height of contraction. 
This response is outwardly typical of the effect of competitive 
blocking agents such as curare, (see Figs. NM 6 a., b., & c.). 
The action of quinuronium however, did not seem to be reversible 
by eserine alone. 
Acetylcholine (20 ug) in the eserinised muscle produced a 
typical muscle contracture which was indicative of muscle 
depolarisation. This state of contracture was rapidly reversed 
by the addition of tubocurerine 1 mgm (a competitive inhibitor 
of acetylcholine). Likewise the depolarisation produced by 
acetylcholine was equally rapidly reversed by 2 mgm of quinuronium. 
Conversely the competitive blockade induced by d-curare (300 mgm) 
could be overcome by the addition of eserine and acetylcholine and 
the apparently competitive neuromuscular block shown by quinu- 
ronium was also overcome by adding eserine (50 ug) and acetyl- 
choline (300 ug). Suxainethonium (succinyl-Choline) (40 ug) 
induced neuromuscular block and contracture in the musculature, 
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31. 
which effect could only be reversed by repeated washing of the 
preparation. This suxamethonium-induced depolarisation colld 
readily be reversed by the addition of d-curare (1 mgm) which 
evidently competed with the suxamethonium at the receptors of the 
post-junctional end-plate region of the muscle. Quinuronium 
(2 mgm) also readily reversed the depolarisation produced by 
succinyl-choline. Amicartalide (10 rnn) was without effect in 
this preparation, 
B. IN VIVO. 
MUSCLES OF CHICKEN PELVIC LDB. 
(Figure N147). The drugs used had similar effect on neuro- 
muscular transmission whether they were administered by the close 
arterial route or intravenously. Smaller doses were effective 
intra-arterially and these did not display generalised systemic 
effects on blood pressure and respiration. The tracings re- 
produced here-under are of drug effects by the intravenous route, 
as such observations are much more informative as regards the use 
of therapeutic doses of drugs and the effects on blood pressure and 
respiration. 
Quinuronium at less than 50 microgram dose was without effect 
on neuromuscular transmission or respiration, although a slightly 
delayed fall in blood pressure was produced. Doses of quinuronium 
100 to 500 micrograms produced a distinct and, at the latter dose, 
very narked potentiation of the muscle contraction. In addition 
the respiratory volume was markedly reduced. Administration of 
r ` 
i 
. 'r` V \ , r^VMMr 
U i q 
f1611111 Ìrfl, 
OdÍlllll 
Ili 
FIG. N14i 7. 
IN VIVO RECORDING OF: (1) CAROTID BLOOD PRESSURE - TOP 
T ' .CING; ( 2 CONTRACTIONS OF DIGITAL EXTENSOR MUSCLES - MIDLï.ú 
TRaCI'vixG; (3) RESPIRATION -- BOTTOK TRACING, IN THE ANAESTHETISED 
Lbk.LSTIC FOWL. dTC. = d-2`UBOCLRe'SNE CHLORIDE; AC. = ACETYL- 
CHOLINE C:HTARIDE; F. = fUiN'UR.O1tlIUÏdi SULPHATE. 
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32. 
quinuronium at the therapeutic dose level (1 nwn per kilo) 
produced marked neuromuscular blockades approaching 504 inhibition 
of contraction. There was a fall in blood, pressure and cessation 
of respiration for a few seconds followed by a much slower 
respiratory movement with greatly reduced tidal volume. 
d-Tubocurarine invariably produced prolonged hypotensions neuro- 
muscular block and slight reduction in both respiratory rate and 
tidal volume, which appeared to be in proportion to the degree of 
neuromuscular block. 
..(no DIGITAL EXTaSOR IMU,Sarde9 OF RAIT IiIND 
Small doses of quinuronium (100 to 1 mg) injected 
intravenously produced a potentiation of the muscle contraction. 
Larger doses (3 - 5 mgm) caused neuromuscular blockade without 
any initial potentiation. Curare (250 ug) produced a competitive- 
type blocks (see Fig. WS). Suxamethonium (300 ug) produced an 
enhancement of muscle contraction. If this dose was then followed 
by another injection (e.g. 200 ug) neuromuscular block ensued. 
In this species, again it was clear that while 150 ug curare 
was about equipotent with 5 mgm quinuronium (full therapeutic dose) 
in respect of the inhibition of neuromuscular transmission: quinu- 
ronium at this dosage caused virtual cessation of respiration for 
a short period; an effect which was more severe than that 
corresponding to d-tubocurarines (see Table îìM2 and Figs. NEO & 9). 
In both species small doses of quinuronium produced 
potentiation of muscle contraction in the supramaximally stimulated 
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33. 
muscle and simultaneously both rate and tidal volume of 
respiration. Larger doses of quinuronium produced partial 
neuromuscular blockade and temporary cessation of respiration 
followed by a profoundly reduced tidal volume. Curare on the 
other hand always produced neuromuscular blockade paralleled by 
degree of respiratory inhibition (see Tables NM & NE2) which 
was in proportion to the neuromuscular block. 
DISCUSSION. 
The investigation of pharmacodynamic activities revealed 
that quinuronium produced marked hypotension. In the rat the 
complete antagonism of this hypotension by mepyramine suggested 
the possibility of its being caused in part by histamine release. 
However, in rabbits atropine seemed to be a good antagonist to 
the hypotension, which suggested a muscarinic type of action. 
In sheep, both atropine and mepyramine save partial protection; 
the former drug being almost a complete antagonist to quinuronium. 
Neither atropine nor mepyramine produced any significant alley - 
iation of the respiratory inhibition which occurred with the 
hypotension. These results emphasised the importance of 
analysing more completely the mode of action of quinuronium in 
producing hypotension. 
In the blood vessels of the rabbit's ear, quinuronium 
produced vasoconstriction which was slowly antagonised by atropine, 
which taken together with the fact that mepyramine consistently 
failed to antagonise the vasoconstrictor action seemed to indicate 
that histaminic effects were not greatly involved in the action 
of quinuronium in this species. This observation was consistent 
with the failure of mepyramine to antagonise hypotensive effects 
in the rabbit. 
While aricarbalide showed no vascular activity itself, the 
compound appeared to antagonise the action of acetylcholine and 
quinuronium in the rabbit ear. 
Quinuronium invariably produced an increase in the vascular 
35. 
volume of the gut and increased the vascular and pulse-volume in 
the limbs of sheep. Only the lowest doses of quinuronium were 
antagonised by mepyramine whereas atropine abolished the vaso 
activity of quinuronium in both gut and limb. The findings were 
consistent with the fall in carotid blood pressure in sheep and 
it seemed reasonable to infer that part of the mode of action of 
quinuronium in inducing hypotension may be on the vascular beds of 
the intestine and limb, and that this action is largely muscarinic. 
In the isolated heart, quinuronium always produced an increase 
in amplitude of contraction which was unaffected by atropine; 
which suggested that the action on the heart was not cholinergie. 
Mepyramine did not antagonise the stimulant effects of either 
quinuronium or histamine. 
In 19]4, Dale and Laidlaw showed that histamine stimulated 
the heart of cat and rabbit, and Went and Lissack (1935) found 
that histamine also stimulated the heart of guinea pig. 
Recently several authors have reported that the common anti- 
histamine agents do not antagonise histamine on the heart of 
guinea pig,(Lockett and Bartlett 1956; Trendelenburg, 1960). 
Although Mannaioni (1960) reported that diphenhydramine antagonised 
the cardiac action of histamine - this could not be confirmed, 
(Bartleto 1963). It is concluded, therefore, that the cardiac 
action of quinuronium could possibly involve some histamine-like 
activity. In the absence of an antagonist this could not be 
established or denied. However, the fact that quinuronium 
stimulated the heart in these circumstances suggested that its 
36. 
cardiac action probably played little part in inducing hypotension 
and that the primary cause of hypotension was a peripheral vaso 
dilation. These experiments take no account of the situation in 
the live animal where homeostatic reflexes may be involved. 
The effect of quinuronium on the smooth muscle of the 
intestine and bladder was inconsistent. On some preparations 
there was no visible action and on others there was increased 
spontaneous activity. In some experiments a contraction of the 
smooth muscle occurred and this was usually seen when a dose of 
quinuronium followed one of acetylcholine. This might be 
explained in terms of an anticholinesterase action of quinuronium 
which was acting on a small residual amount of acetylcholine. 
This idea was supported by the fact that in all these experiments, 
pre-treatment with euinuronium resulted in a marked potentiation 
of all subsequent doses of acetylcholine which seemed to be a 
possible manifestation of anticholinesterase activity. Similar 
results were obtained when recording the flow of saliva from the 
parotid duct of sheep. In this preparation large doses of 
quinuronium alone always induced a marked increase in salivary 
flow. .Atropine effectively blocked (i.e. antagonised) the 
activity of acetylcholine and quinuronium on the smooth muscle 
of the intestine and bladder and on salivation. 
These results provided confirmation of the clinical obser- 
vation that quinuronium stimulated the acts of defaecation 
salivation and micturition: all of which could be prevented by 
premedication with atropine. Amicarbalide was itself inactive 
37. 
but showed partial antagonism for the action of acetylcholine and 
quinuronium on smooth muscle. The observation supported the 
atropine-like activity of amicafbalide which was observed on the 
blood vessels of the rabbit's ear, 
quinuronium produced a very marked and prolonged stimulation 
of gastric acid secretion in rats, which was never completely 
antagonised by atropine. ktropine has been reported to be an 
incomplete antagonist to gastric secretion(Gray and Ivy, 1937; 
Code, 1951). Nevertheless, in view of the fact that in these 
experiments atropine appeared completely to block the action of 
acetylcholine, it seemed likely that the atropine-resistant factor 
in the action of quinuronium was probably not cholineraic. 
repyramine failed to antagonise the gastric secretion induced by 
histamine, quinuronium or acetylcholine, and in fact secretion 
tended to be enhanced, (Table G.2.). Mota (1960) showed that 
mepyramine released histamine in vitro and many authors have 
reported that antihistaminic agents themselves may stimulate 
gastric secretion and do not antagonize the gastric effects of 
histamine, (Paton and Schachter, 1951; Loew, 1950; Ashford, 
Heller and Smart, 1949). Hence in the absence of a histamine 
antagonist it was not possible to show whether the gastric 
secretion stimulating component of quinuronium not antagonised 
by atropine, was histamine. Further support of anticholinesterase 
action was the specific potentiating action of quinuronium upon 
the action of acetylcholine on gastric secretion. Neostigmine 
also potentiated acetylcholine, but compound 48/80 which acts 
by releasing histamine, (Paton and Schachter, 1951; Smith, 1952) 
38. 
did not, 
The stimulant effect of amicarbalide on gastric secretion 
and the failure of either atropine or mepyramine to antagonise 
this could not be explained on the evidence so far available. 
However, it was interesting to observe that amicarbalide was 
partially antagonistic towards the action of acetylcholine whioh 
supported the data on the atropine-like activity of this drug 
in smooth muscle, 
Quinuronium was shown to have a dual role in affecting 
neuromuscular transmission. Small doses potentiated the supra- 
maximally stimulated nerve muscle preparation whereas bigger 
doses produced neuromuscular blockade. When compared with the 
action of curare, it appeared that the action of quinuronium at 
the neuromuscular junction could not be distinguished from the 
former compound. It has been established that the isolated 
chicken biventer muscle is especially useful as a method for 
detecting depolarising agents which produce sustained contracture 
of the muscle, (Ginsburg and aarriner, 1960). Eserine by virtue 
of its anticholinesterase action produces neuromuscular blockade 
and sustained contracture, Most anticholinesterase compounds 
have such an effect at the neuromuscular junction, (Modell and 
Krop, 1946; Holmes and Robbins, 1955; Brown et al, 1957), and 
furthermore they have the ability to reverse the competitive 
block produced by curare, (Blaschko, Balbring and Chou, 1949). 
Quinuronium like curare antagonised the contracture produced by 
eserine and acetylcholine or succinylcholine and conversely 
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eserine and acetylcholine readily reversed the competitive 
blockade of curare or quinuronium. It seemed, therefore, that 
quinuronium stimulated neuromuscular transmission at low doses, 
possibly by an anticholinesterase action, and at higher doses 
produced neuromuscular block which was probably a result of 
competitive antagonism for the nicotinic actions of acetylcholine 
and not associated with anticholinesterase activity. 
Acute experiments in the chicken and rabbit, in which the 
relative effects of ouinuronium on respiratory activity and 
neuromuscular transmission were compared, showed that this agent 
had a more profound effect on respiration than on neuromuscular 
transmission. Nhen comparing doses of quinuronium and 
d-tubocurarine which are equi-active at the neuromuscular junction 
it was clear that quinuronium had a more marked effect on 
respiratory movement, Moreover, the smallest dose of quinuronium 
produced a potentiation of neuromuscular transmission concurrent 
with respiratory inhibition. It is suggested, therefore, that at 
therapeutic doses of quinuronium, neuromuscular blockade plays 
a significant part in producing respiratory inhibition, but that 
a large part of the depression of respiratory movement is 
independent of neuromuscular block ami may be partly the result 
of histamine or muscuranic bronchoconstriction. The central 
depression as a result of anticholinesterase activity, (Modell and 
Krop, 1946; Holmes and Robbins, 1955), and the inhibition of 
oxygen metabolism, (Kronfeld, 1959) are also possible influences. 
40. 
S E C T I O II 
ANTICEUUNESTERASE PROPERTIES 
INTRODUCTION. 
Despite the long-recognised side effects of euinuronium, the 
precise elucidation of the mode of toxicity of this compound did 
not attract much attention until recent years, (Kronfeld, 1959), 
(Runnier and Laue, 1961). The last named authors showed that in 
a proportion of dogs and sheep treated with quinuronium sulphate, 
a fall in circulating cholinesterase activity was detectable. 
These authors had anticipated such activity on the grounds that 
quinuronium was a substituted urethane. 
Several considerations must be made of Rummier and Laues 
work before attempting further investigations. These authors 
used twelve dogs and six sheep initially. Animals had venous 
blood samples withdrawn before and after injection of quinuronium 
(% aqueous up. to 0.1 ml per kgm.). Whole blood was subjected 
to manometric (varburg) estimation of cholinesterase activity. 
Four dogs and four sheep failed to show any reduction in enzyme 
activity. In the first instance, therefore, it seemed important 
to repeat this investigation both in vitro and in vivo in a number 
of species. 
Runnier and Laue (1960) proceeded to test a number of anti- 
dotes and to assess their efficacy on clinical grounds: no 
estimation of cholinesterase activity being carried out on these 
"premedicated" animals. 
The antidotes used were: 
1. Pyridine 2- aldoxime methiodide 
2. Atropine sulphate 
3. An unspecified analeptic. 
Their results may be tabulated as follows: 
(a.) All animals injected with quinuronium at a dose rate 
of 5 mgm per kilo died if unpremedicated. 
(b.) One sheep was premedicated with PAM alone and died. 
(c,) Two sheep which received PAM and an analeptic likewise 
died. It has been reported that although the neuromuscular 
effects of anticholinesterase toxicity (both organophosphorus and 
quaternary salts) are readily reversed by oximes, the muscarinic 
and central neural symptoms are not appreciably influenced by 
exime administration, (Grob and Johns, 1956). In the sheep in 
question, therefore, it is conceivable that they died in part as 
a result of central depression of respiration and mmscarinie action 
on the heart. 
(d.) Of the four animals pretreated with atropine alone, 
one died and the other three showed toxic signs; whereas of the 
twelve sheep premedicated by these authors with atropine and 
2.P.A.M. combined, only two died and all others showed definite 
toxic signs which were said to be clinically less severe than in 
those which had received atropine alone. One cannot conclude 
positively from such an experiment that a combination of atropine 
and PAM offers significant advantages over atropine alone. 
No investigation was made by these workers to correlate the 
premedicant therapy with directly determined cholinesterase 
4.2 . 
activity. 
It therefore seemed important: 
(i) To confirm the anticholinesterase activity of quinuronium 
in vitro and in vivo in a wide variety of species. 
(ii) To test directly the action of 2.P.A.M. in sheep which had 
received a large dose of quinuronium up to 2 mgm per kilo. The 
dosage rate used by Rummler and Laue is thought to have been too 
great (5 mgm per kilo) in view of the fact that the drug manu- 
facturers recommended dose rate is of the order of 1 mgm per kilo 
and the L.D.50 is of the order of 2 to 4. mgm per kilo, (Kronfeld 
1959). It was therefore decided to adopt 1 to 2 mgm per kilo 
as the experimental dose range in the living unanaesthetised 
sheep and to scale this down to similar proportions for use in 
in vitro investigations. 
(iii) To compare quinuronium and amicarbalide on cholinesterase 
enzyme preparations. 
(iv) To try to determine the mechanism of action of quinuronium 
sulphate and to compare this with a known standard, such as 
eserine. 
METHODS. 
CHOLINESTERi..z..\E LSTIMATIONS. 
The method of choice from the point of view of accuracy of 
determination has been the :4arburg manometric method. 
For convenience, and for efficiency in handling large 
numbers of tissue samples from a variety of animals it was 
decided to use the colorimetric method for determining carboxylic 
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esters first described by Feigl, Anger and. Frehden (1934) as 
modified by Hestrin (1949). The method was applied to the study 
of anticholinesterases by Katsch (1955)and by Fleisher, Pope and 
Spears (1955). These authors published details of the esti- 
mations and the degree of precision which could be expected. 
Augustinsson (1954) described the colorimetric method as con- 
venient for small quantities of tissue and applicable to a wide 
variation in pH and enzyme concentration in almost any buffer 
solution. The limits of measurement were from 5.0 to 0.04 micro- 
mole. The accuracy was less than with either manometric or 
titrimetric methods and some 2O to 30A of the ester had to be 
hydrolysed in order to give the best results. 
A good index of activity of a cholinesterase inhibitor has 
been shown to be an expression of 50o, activity. This is the 
logarithm of the reciprocal of the molar concentration of 
inhibitor causing 5q/i, inhibition of enzyme activity; i.e. pl50 
(Blazchko, Billbring and Chou (1949)), (Bergmann et al (1950)), 
and(Myers 1952). 
THE CHEMICAL REACTION. 
The basic chemical reaction described by Feigl et al (1934) 
is as follows:- 
The ester reacts in alkaline solution with hydroxylAmine 
to form acethydroxamic acid: 
(i) (C113) .N. CH2 CH2 .0 CUCH NH2 OH 
3 
(CH) 4 CH2 .CH2 OH 011700 *MOH 
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The hydroxaniic acid so formed reacts in acid solution with 
ferric chloride to form a soluble red complex: 
(ii) 0113 00 NHOH + Fe01 
3 
--Om* 
[c1-1 . C = O - - - -...- Fe 
3 
NH - 0 
J 
- 
3 
+ 3110]. 
The intensity of colour is proportional to concentration 
of acetylcholine present. 
OHLYIOAL ±-100EDURES ENZWE PREPARATION TECHNIQUES. 
1. Acetylcholine standardisation 
(a) Aliquots of 0 (control) 0.2, 004, 0.60 0.8, and 1.0 ml 
of buffer acetylcholine solution are pipetted into centrifuge 
tubes and phosphate buffer added to each to give a final volume 
of 1.0 ml. 
(b) 2 El of alkaline hydroxylamine is added to each tube 
which is shaken vigorously. 
(c) After at least one minute, 1.0 ml of 33,4 1101 solution 
is added (attains final pH of approx 1.2) and 1.0 ml of ferric 
chloride solution added. N.B. Vigorous shaking is undertaken 
after each addition to avoid any bubble fomation during colour 
absorption readings. 
(d) Absorbance of colour in each tube is measured at 540 mu 
using a control tube to adjust the instrument to 100. lbsor- 
bance can be plotted against the known acetyldholine concen- 
trations and the curve is used thereafter as a standard for all 
e 
determinations. 
2. Procedure for plasma (or other enzyme preparation (e.g. 
tissue homogenate.).7 
(a) A quantity of plasma [volume 0005 to 0.5 ml depending 
on species and experimental conditions (Table 0E1)2 is expelled 
into 1.0 ml of buffer acetylcholine solution. The pipette is 
rinsed three times in the buffer. The time is noted and the tube 
immersed in water at 37CC after thorough mixing. 
(A standard of 1.0 ml buffer acetylcholine solution without 
plasma and a control of 1.0 ml buffer without Ach are also made up.) 
(b) After an exact time (20-30 minutes depending on the 
species) 2.0 ml of alkaline hydroxylamine is added to all tubes 
and the acetylcholine estimation proceeds as described above after 
centrifugation to remove suspended particles. 
(c) Plasma is added to the standard and control immediately 
after the hydroxylamine. The standard allows one to correct the 
readings for non-enzymatic hydrolysis of acetylcholine and the 
control allows one to adjust the colorimeter to zero. 
3. Procedure for erythrocytes. 
(a) The packed red cells are washed three times with an 
equal volume of normal saline, centrifuged and decanted after 
each washing. 
46. 
(b) One volume of washed red cells is pipetted into five 
volumes of water to haemolyse the cells; rinsing the pipette 
thrice in the solution. 
(e) A volume of haemolysate (Table OB1) is pipetted into 
1.0 ml buffer Ach. 
(d) The estimation proceeds exactly as for plasma using 
standard and control tubes with centrifugation in all cases to 
remove suspended matter. 
4. Procedure for whole blood. 
(a) Heparinised whole blood is mixed with 0.01/, saponin 
solution at the rate of one volume of blood to four of saponin. 
(b) A volume of haemolysate 0.5 - 1.0 ml (Table OB1) is 
'added to 1.0 ml acetylcholine buffer at zero time. 
(c) At a predetermined time (Table CH1) the reaction is 
stopped by adding alkaline hydroxylamine and the procedure 
carried out exactly as described above. 
The standard curve was used to determine the amount of 
acetylcholine in each sample after incubation with the enzyme 
(with or without inhibitor). The cholinesterase activity is 
expressed as micromoles of acetylcholine hydrolysed by 1 ml of 
plasma, erythrocytes or whole blood in one hour. (The relation- 
ship between acetylcholine concentration and colorimeter reading 
was linear over the range of concentrations used). 
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THE ANTICHOLINESTERASE ACTIVITY OF UINURONIUM SULPHATE 
AND AMICARBALIDE ISETHIONA1E 
, IN VITRO. 
Blood samples were taken from horses and sheep by jugular 
venepuncture using a wide bore needle and collecting blood in a 
heperinised stoppered test tube. Cattle blood was collected at 
slaughter from the severed jugular and carotid. 
The drug compound was added in concentrated solution to the 
tissue fluid to give the appropriate final concentration as shown 
below. The mixture was then incubated at 3700 for one hour, 
after which an aliquot of drug incubated tissue fluid was added 
to i ml of acetylcholine buffer solution and this mixture was 
incubated at 37o0 for thirty minutes (see Table CHi). 
Drugs. Quinuronium sulphate in phosphate buffer approximated to 
blood concentration followed a therapeutic dose, i.e. 20 ug per m1 
of plasma or r.b.c. haemolysate; amicarbalide isethionate on a 
similar basis approximated to 100 ug per ml of plasma or r.b.c.'s.; 
eserine salicylate was used as a control at a concentration of 
20 ug per ml. 
Ll__ZtIATKu;13LooJI)IxgagiME212L2EEDEAEM2LL 
Nine species were involved in this investigation and whole 
blood haemolysates were made from blood samples obtained as 
indicated in Table CH3. Alquots were taken into a series of 
stoppered test tubes and to each was added a quantity of inhibitor 
8. 
compound so covering a range of drug concentrations as shown below 
in Table CH2. 
TABLE 0E12. 
ESERINE 
QUINDRONIUM 
ANICARBALIDE 
00. 
0,. 
0, 
5 2 
,7 
-.' 9 
r, 
....,, 
100 
10, 
10, 
25, 
25, 
25, 
50, 
50, 
50, 
100 ug/M1 
100 ug/ml 
100, 500 ug/M1 
and 1 mgm/M1 
t each drug concentration, estimations were always carried 
out in pairs and the mean of two readings taken. 
All the tubes now containing the required concentration of 
releaser compound were incubated for one hour at 37°C in order that 
enzymic inhibition could take place. After one hour had elapsed, 
1 ml of buffer acetylcholine was added to each tube and all tubes 
were again incubated at 37°C for a further twenty to thirty 
minutes (see Table CBI) after which time the reaction was arrested 
by adding 2 ml of alkaline hydroxylamine to each tube and the 
estimation carried out as described previously using a non- 
acetylcholine tube (blank), and an unreacted acetylcholine tube 
(standard). 
The degree of enzymic inhibition was determined at each 
dose level for the three compounds, eserine quinuronium and 
carbalide in the nine species, horse, sheep, cow, pig, dog, 
chicken, rabbit, guinea pig and rat. 
TABLE CH5 
METHODS OF BLOOD SALTLING 
SPECIES 
.1.1.*001111.0111I/11 
METHOD OF OBTAINING 
WHOLE BLOOD SAMPLE 
HORSE 
SHEZP 
COW 
PIG 
Jugular venepuncture into 
heparinised tube 
Mixed arterial - venous blood at 
slaughter into heparinised tube 
DOG Heart puncture at the time of 
euthanasia 
CHIOKEN wing vein ) 
into heparinised tube 
RABBIT Ear vein ) 
GUINEA PIG. 
RAT 
Whole animal heparinised (intraven.), 
killed by stunning and mixed 
blood collected from the neck 
Ll_cTHEEEEEZSEIEaZEEDLUBSTRATECONCEFITRATIONULONTHE 
ENZYME INHIBITION INDUCED BY CUINURONIUM SULPHATE JIND EST,IRINE 
SALICYLATE. 
The techniques employed are similar to those described above 
for the in vitro activity of the inhibitors on whole blood 
haemolyzate. 
1. Sheep blood was haemolysed by mixing with four volumes of 
0.1c/c saponin solution. 
2. 0.5 ml of this blood solution was added to 2 ug of quinuronium 
or 1 ug eserine each contained in 005 ml phosphate buffer 
solution. 
50. 
3. The blood and inhibitor were incubated together at 37°C for 
one hour; after which varying quantities of acetylcholine were 
added to a duplicated series of tubes (each of which now contained 
the 1 ml of blood - inhibitor mixture) as follows:- 
Acetylcholine 1, 2, 44 8, 20 4- 40 u moles. 
¿f. The acetylcholine was reacted for twenty minutes at 37°C 
with the blood enzyme - inhibitor system and the hydrolysis was 
arrested after twenty minutes by the addition of 2 mis alkaline 
hydroxylamine to each tube. N.B. In the case of the tubes 
containing 8, 20 and 40 u moles, the contents of each tube was 
diluted by factors of 2, 5 10 respectively to bring the potential 
acetylcholine concentration into the range of the standard curve 
which is employed to calculate the acetylcholine concentrations 
from the calorimetric readings (see above). Before the final 
calculation these results had to be multiplied by the dilution 
factor. 
5. Together with this series of tubes; another containing the 
range of unreacted acetylcholine concentrations was employed as 
standard and control Ach reactions (uninhibited) were also 
estimated. The colorimeter was set to zero using a "non- 
acetylcholine" tube which contained all the reagents and solutions 
excluding the substrate. 
Drugs* Quinuronium and eserine were investigated. 
51. 
2.; IN VIVO. 
a) ANTICIIE)LINESTERAS ; STUDIES IN SHEEP. 
In view of the work carried out by Rumm1er and Laue (1961) on 
the living, animal, in which lowering of circulating cholinesterase 
activity was shown after injection of quinuronium; it was thought 
necessary to investigate more fully the events taking place in the 
blood of sheep injected with a therapeutic dose of a number of 
anticholinesterase compounds. The work of Rummler and Laue 
(1961) had suggested an easily reversible inhibition by quinu 
ronium, and it was shown in the previous experiments that in fact 
quinuronium tended to resemble the mode of action of eserine and 
to be of the competitive type (substrate reversal). 
Technique. The sheep was chosen as the experimental animal both 
for convenience and to compare with Rum ier and Laue's work. 
The animals were all South. Country Cheviots of approximately one 
year old which had been housed in the department for several weeks 
before experimentation began. The animals were of mixed sexes 
(including castrated males) taken at random. 
The first blood sample from each sheep was taken immediately 
prior to an injection of atropine which was thirty minutes before 
the injection of the suspected anticholinesterase agent. Thus 
after this lapse of half an hour (to allow for full atropinisation, 
1 mgm per kilo) a further blood sample was taken; immediately 
after which the animal received the anticholinesterase drug. 
Blood samples were taken at five, ten, fifteen, thirty and sixty 
minutes; two, three, four, six and twenty -four hours; and again 
on the seventh and fourteenth days post injection (Table CH7 ), 
52. 
and were assayed for cholinesterase activity by the colorimetric 
method already described. 
Drugs . :Eserine salicylate; quinuronium sulphate; ami carbalide 
isethionate; octamethylpyrophosphoramide (O.M.P.A.) and 
atropine sulphate. 
b' THE E '.bth OT ON CIRCULATING CHOLINESTERASE OF A SECOND 
DOSE OF Qt3IIWRONflJM. 
In the same manner as already described, sheep were bled and 
injected intravenously with atropine (1 m n per kilo). After 
thirty minutes a blood sample was taken and immediately followed 
by a subcutaneous injection of quinuronium. Further blood 
samples were taken at five, fifteen, thirty and sixty minutes; 
at two, three, four, six and twenty-four hours, and again on the 
seventh and fourteenth days, as before. On the fourteenth day, 
the process of injection and blood sampling was repeated exactly 
as described above (see Table CH8 and also Appendix rig. E). 
(c) STUDIES WITH PYRIDINE 2- JJDOXI& . i'Íi THIODIDE IN SHEEP. 
Rummlr and Laue (1961) were the first workers in this field 
to conclude that quinuronium sulphate was an anticholinesterase 
compound although many authors had referred to some form of 
cholinergic stimulation for almost thirty years before this 
publication. The "symptoms" described by certain authors: 
(Sargent, et al, 1933; Smythe, 1935; Cernaianu, et al, 1935; 
and Kikuth, 1935) as early as 1935 were to some extent consistent 
with what we now recognise in cases of acute acetylcholine 
53. 
poisoning following the administration of a potent anticholin 
esterase substance such as D.F.P. or the insecticides Malathion 
and Parathion to a m-smal. As noted previously, Runmler and. Laue 
(1961) suspected that quinuronium might have anticholinesterase 
properties in view of the similarity of its molecule to certain 
urethanes known to possess this activity. 
These authors thought it possible that the recently intro- 
duced idea of organophosphorus cholinesterase inhibition being 
relieved by PAM (pyridine 2-aldoxime methiodide) (Wilson and 
Ginsburg, 1955), (Hobbiger, 1955, 1956, 1957 and 1959), and 
(Rutland, 1958), might be en indication that premedication of an 
animal (in this case sheep) with PAM could have beneficial 
effects in preventing the onset of acetylcholine poisoning as 
a result of therapy with quinuronium. In fact, useful prophy- 
laxis had been reported in 1957 by Brown, Kunkel et al, in the 
case of organophosphorue poisoning by the use of a eombination 
of atropine and PAM. 
Formula. 
PYRIDINE 2 -ALDOXIVa EETBIODIDE 2.P.A.1M-) 
CH3 
N1+ CH=NOH 
54. 
This form of prophylaxis was administered by Rummler and 
Laue (1961) to sheep prior to quinuronium therapy as has been 
explained above, the outcome was appraised purely on the result 
of clinical observation which could not (according to published 
data) necessarily be interpreted as a significant alleviation of 
toxicity by PAM. 
The observations on Rummler and Laue 's publication led 
naturally on to a direct study of cholinesterase activity 
circulating in the blood of sheep which had been premedicated with 
atropine and 2.P.A.M. 
Techniques. 
1. In view of the observation that may in its own 
right bring about interference with acetylcholine metabolism, 
(Grob, 1961); possibly inhibiting the cholinesterase enzyme as 
such, it was decided to investigate the levels of circulating 
cholinesterase in sheep which were given a full dose (20 mgm per 
kilo) of 2.P.A.M. intravenously. 
Three sheep were so treated. The animals each received 
20 mgm per kilo of pyridine 2-aldoxime methiodide into the 
jugular vein immediately following the collection of a control 
blood sample. Jugular blood samples were then taken at 
intervals of five, fifteen and thirty minutes; also one and two 
hours after injection; and cholinesterase activity estimated. 
2. Three groups of four sheep were used to investigate the 
effects of 2.P.A.M. upon the cholinesterase inhibition induced by 
quinuronium, eserine and 0.M.P.A. Each sheep was injected with 
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55. 
atropine sulphate (1 mgm per kilo) intravenously. After thirty 
minutes a control blood sample was taken and PAM (20 mgm per kilo) 
injected intravenously. At the sage time, quinuronium, eserine 
or 0.M.P.A. was injected subcutaneously and venous blood sangles 
were taken as previously described at five, fifteen and thirty 
minutes; also at one, two, four, six and twenty-four hours after 
injection, and again on the seventh day. 
RESULTS. 
THE WlICHOL1NESTERASE ACTIVITY OF cUIEURONIUM AND AMI- 
CARBALIDE. 
IN VITRO. 
jaPLASialERYIJICLCYTESJIFBORSE220WANRSeELZP. 
serine was confirmed as being a potent inhibitor of 
cholinesterase activity and quinuronium was approximately equi- 
potent with eserine. Both drugs had an approximately equal 
action on each blood fraction. Amicarbalide had a very weak 
action on cholinesterase activity. (Results are shown in 
Table CH4 and Figs. CHI, 2 and 3). 
L12.E13199212E.TEL_R12010MSES42111\TESMRASE. 
In all species, curves were plotted of the percentage 
inactivation of the enzyme by the drug (ordinates); against 
the concentrations of drug used (abscissa) and results are shown 
in Fig. CH4 (eserine2 sheep), CH5 (quinuronium) and CH6 (ami- 
carbalide.) 
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FIG. (,11. 2. 
TTHE 
INHIBITION BY EIE, QÜINU`2ONIUNt ? AtiM]T- 
C.EALIDE IN VITRO, OF P.LIÉiSurit3. AND ERYTHROCYTE (Z'.b.C.) 
CHOLINESTERASE ACTIVITY IN SHEEP. 
ORDINATE = % CHOLINESTERASE ACTIVFY. 
VALUES ARE MEANS OP FOUR ANIMALS mS.L+' S.E. 
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FIG. CH. 3. 
THE INHIBITION BY ESr..RIiVE, QUIR1URONIUM AND fiWIa 
CAR.BEAISDE IN VITRO, OF PLASMA AND ERYTHROCYTE (r.b.c. ) 
CI-iOLIN.ESTERkSE ACTIVITY IN CATTLE. 
ORDINATE = % CHOLINESTERASE AGILITY. 
VALUES _ ,,RE MEANS OF FOUR ft A NDTIS - S.E. 
FIG. CH. 4. 
IN VITRO INHIBITION OF 1tiiIOLE BLOOD CHOLINESTERASE 
ACTIVITY BY E"SE.tNE, MEASURED BY THE COLORD1TRIC METHOD. 
( THE CURVE REPRESENTS THE SITUATION IN ALL SPECIES, 's'vHICH 
MAY BE SEEN IN THE APPENDIX, FIGS. A -- J. incl.) 
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FIG. CH. 5., 
SPECIES VARIATION IN INHIBITION OP WHOLE BLOOD 
CHOLINESTERASE ACTIVITY BY QUINURONIUM SULPHATE, MEASURED 
BY THE COLORIMETRIC METHOD. 
ORDINATES= LIME; INACTIVATION. 
ABSCISSAE = MICROGRAM. QUIEURONIUM PER BLOOD. 
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FIC4.. GE. 6. 
SPECIES COMPA-RI Ll)N OF INIUBITION OF WHOLE BLOOD 
CHOLINESTERASE ACTIVITY BY ANICARBAL.IDE I SEMI °NATE 
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ORDINATES = % ENZYIE flÂCTI WT ION. 
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56. 
It is seen from Fig. 0114 (which is the curve produced by 
incubating a range of concentrations of eserine with sheep blood), 
that such a curve begins at very low dose levels and rises very 
steeply. The dose range from 1 to 5 ug/nl covers 70 to 80,ï40 
enzyme inhibition in all nine species in which the shape of the 
curve for eserine was virtually identical in all epecies as can 
be seen in Appendix Figures A to J (incl.). 
The curve of cholinesterase inhibition by quinuronium 
(Fig. CH5) was steep and similar to eserine in horse, sheep, cow, 
pig and rabbit. In dog, chicken and rat the curve was steep but 
rapidly achieved a maximum (equilibrium under the prevailing 
conditions) at about 5q% inhibition. In the guinea pig, the 
slope of the curve was least of ell nine species. 
A comparison of pI50 figures (i.e. logarithm of reciprocal 
molar inhibitor concentration required to produce 50;',, enzyme 
inhibition: Blaschko, Htilbring and Chou (1949)indicated that in 
the whole blood of horse, cow, sheep, rabbit and pig quinuronium 
had the same degree of activity as eserine; whereas in rat, 
guinea pig, chicken and dog quinuronium was less active than 
eserine in respect of cholinesterase inhibition under the experi- 
mental conditions (Table 0115). 
In the case of amicarbalide very little inhibition could be 
produced in any species save the horse in which a fairly steep 
curve was obtained, indicating some 502, inhibition at a dose level 
of 50 ug/ml. In the guinea pig no inhibition by amicarbalide 
could be detected in the conditions of the experiment and in the 
seven other species, varying slight degrees of inhibition were 
TABLE CH6. 
THE EFFECT OF INCREASING SUBSTRATE CONCENTRATION UPON 
CHOLINESTERASE INNHIBITION PRODUCED BY ESERL E 
QED QUINURONIUM 
SUBSTRATE 
CONCENTRATION 
( u moles 
Ach.) 
PER CENT 'r:NGY%E INHIBITION 
AFTER INCUBATION. WITH:- 
R 
(liSìRlçfiNnE (1 ugtn) 
:UZ( NUkONItRvi 
( 2 ugm) 
79.011.5 06.016.00 
89.013.0 80.016.40 
81.0=4.5 94.0=7.80 
75.014.9 87.015.20 
20 30.015.6 21.0*7.30 
40 15.014.5 10.0} 6.4 
Figures are expressed as means with standard error. 
Number of estimations for each mean = 4. 
57. 
produced from 10i0 to 301/0 at a concentration of micarbalide 
ranging from 100 ug to 1 mgm per ml. A comparison of pI50 
figures showed that in horse whole blood amicarbalide had anti- 
cholinesterase activity which was of the same order as eserine 
and quinuronium. In sheep whole blood amicarbalide activity 
was rather less than eserine, but in rabbit, pig, rat, chicken 
and dog the activity was very much less (see Table CH5). In 
appendix Figures A to J (incl.) the three respective curves 
(corresponding to inactivation of whole blood of each species by 
the three inhibitor compounds) are drawn on the sane diagram to 
allow for a comparison of activity of the three agents in each 
individual species. 
Lç)TH-..._.p-ITZTOFI\ICIS.EDSUBSJRAT:ECO_NCENTRhTIONH2N 
ENZYME INHIBITION INDUCED BY (UINURONIUM AND ESERINE. 
Results were calculated as the percentage inactivation 
produced by a constant amount of inhibitor (eserine or quinu- 
ronium) in the presence of varying quantities of substrate (Ach). 
In the case of both eserine and quinuronium it was shown 
that an increase in the concentration of acetylcholine up to 
40 u moles per ml resulted in a diminished ability to inhibit the 
enzyme cholinesterase. Up to and including 8 u moles per ml the 
percentage inhibition remained fairly constant and thereafter 
fell markedly, see Table CH6 and Figs. 0H7 and 8. 
PER CENT 
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FIG. CH. 7. 
IN VITRO SUBSTRATE (ACETYLCHOLINE) GbNFETITION OF 
THE INHIBITION OF WHOLE BLOOD CHOLINESTERAS..' ACTIVITY 
BY ESERINE. 
PER CENT 
INHIBITION 
OF 
ENZYME 
50 
O 
100 
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1 
O 1 2 4 8 16 32 64 
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(r moles ) 
FIG. CH. 8. 
IN VIN VITRO SURSTRfi.TE 
, (ACETYLCHOLINE') COá:1PETITIOl1 OF TIE I.iTHIBITION OF WHOLE BLOOD CHOLINESTERASE ACTIVITY BY h;UINURONIMi. 
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58. 
IN VIVO. 
(a) ANTIGHOLINESTERASE STUDIES IN SHEEP. 
(Table 0117 and Figure 0H9) 
Eserine salie late 20 mgm (). sheen). 
Eserine produced a rapid and profound fall in blood 
cholinesterase activity. Enzymic activity fell to a mean of 
37, (1'9) within an hour. Thereafter activity gradually returned 
to normal: within six hours enzymic activity was 8/4L, (t4) of 
normal and at twenty-four hours was 95¡,, (4) of normal. At the 
seventh and fourteenth days, the activity of the enzyme was 
respectively 1037', and 105A, of normal. 
Injection of the chemotherapeutic agent was followed by a 
very rapid fall in blood cholinesterase activity to a mean of 
41;4, (4) within thirty minutes, after which the enzyme activity 
returned to normal more slowly than with eserine. At six hours 
the activity was 68/0 (17), and at twenty-four hours 884,, (17). 
The activity of the blood on the seventh and fourteenth days 
respectively was 95;,, (t4) and 940 (t4) which could not be 
regarded as significantly different from normal. However, despite 
lack of statistical significance, the blood enzyme activity of 
these four sheep appeared to remain depressed over the two weeks 
when compared with the four sheep treated with eserine. 
Amicarbalide isethionate 200 mn. 
Amicarbalide reduced the blood cholinesterase activity to 
only about 70,k. At the fourth and sixth hours the enzyme levels 
were respectively 90 and 89 h (1-6) which were well within 
100 
50 
ESERINE 
0 5 15 30 60.2 3 4 6 24, ,7 
Z MÌN. ÑR. DY. 
100, QUINURONIUM 
50 
t 
MIN. HR. DY 
ORDINATES :°/0ENZYMIC ACTIVITY 
100 
50 
100 
OCTAMETHYLPYROPHOSPHORAMIDE 
1 
MIN. HR. DY. 
ABSCISSAE : TIME 
MIN.= MINUTES 
HR.= HOURS 
DY. = DAYS 
FIG. CH 9. 
TïTE INHIBITION OP WHOLE BLOOD CHOLINESTERASE ACTIVITY IN 
A`l'HOPID1TSED SHEEP IN VNO BY SUB-CUTANEOUS INJÈC`ï'ION OF: 
(I) Ea ERINE SALICYLATE; (2) OCTANGTHYL PYE:OPM.:;iPHON.AIvîIDE; 
(3) WlydURoNlUK SUI.PHiITE; (4) AtICARBr'iIIDï; ISETHIONATria. 
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59. 
normal limits ana remained so over the following two weeks. 
Qgtunethy1pyrophosphomrnidelOO 
According to DuBois, Doull & Coon (1950) the L.D.50 of this 
compound varies from 5 to 17 mgm per kilo depending on the species 
and route of administration, 5 mgm per kilo was chosen as an 
initial sheep dose, This compound was slow in affecting the 
cholinesterase activity; the lowest reading (15 - 20Y-0) being 
attained after one and a half to two hours. Thereafter, recovery 
was very slow. At the sixth hour enzymic activity remained 
depressed at 15 - 2O and at twenty-four hours enzyme activity 
was only ¿i-O) of normal. By the fourteenth day post injection 
however, the activity of the enzyme was within a few per cent of 
normal. 
IL2122HZ-EVVECTOPLOLSECNDDOSEOFLNURONIUM. 
Within one hour of the second injection of quinuroniam 
(day 14) the level of circulating cholinesterase was a mean of 29b 
normal which was 10 lower than the enzymic activity following 
the first injection, (Table CH8), and in spite of the high dose 
of atropine which had been used, the sheep showed more marked 
toxicity than after the first dose of quinuronium, (see also 
Appendix 10. 
(0). STUDIES WITHEIB1DINE 2..ALDOXINE KETHIODIDE IN- SE-YRKP, 
1. 2.P.A.M. alone injected intravenously in sheep produces a 
very slight but nevertheless positive lowering of blood 
Cholinesterase (Table CH9). The effect was very transient, and 
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normal enzyme activity was recorded after 30 minutes post PAR. 
2, From Table CH9, it can be seen that premedication with 
PAM intravenously immediately prior to ouinuronium therapy 
did not have apy significant effect on the lowering of cholin- 
esterase enzyme activity. A further injection of 2.P.A.M, just 
prior to blood sampling at two hours did not alter the course of 
events, which was in fact no different from that in sheep to 
which PAM had not been administered (Table CH7). Blood 
cholinesterase activity was some 95/0 normal at the sixth hour 
and remained similar at twenty-four hours. By the seventh day the 
enzyme activity was within a few per cent of normal. 
2.P.A.M. likewise failed to protect the sheep enzyme in 
any way against eserine, (Kewitz, Wilson and Nachmahnsohn). 
However, in the case of 0.M.P.A. 2.P.A.M. showed a definite 
tendency to slow the rapidity of onset of enzyme inhibition, but 
the ultimate minimum activity (18J/0) was not significantly 
different from that in sheep which had not received 2.P.A.L. 
A further injection of 2.P.A.M. immediately prior to the 
blood sampling at two hours post-O.M.P.A. showed a significant 
"recovery" in the enzyme, so that over the next two hours, 
cholinesterase activity was about 55,, of normal. By the sixth 
hour activity had fallen to 20,ic of normal and at twenty-four hours 
was 51:. After the lapse of one week the enzyme activity was 
93 of the original control reading. (Compare Table CH7 with 
OH9). 
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DISCUSSION. 
Mendel and Rudney (194.3) and Mendel, Mundell and Rudney (1943) 
showed that two distinct cholinesterase enzymes existed, both 
capable of hydrolysing acetylcholine and both sensitive to the 
effects of eserine. The two enzymes were called "true" and 
"pseudo" cholinesterase. True cholinesterase as found in brains 
and in human and horse erythrocytes was most active in hydrolysing 
choline esters most closely resembling acetylcholine and is 
now usually referred to as specific acetylcholinesterase. 
Pseudo-cholinesterase has greatest activity towards esters closely 
resembling butyrylcholine and is referred to as non-specific or 
butyryl-cholinesterase. 
It is known that the non-specific cholinesterase may be 
almost completely inhibited without an animal showing signs of 
acetylcholine poisoning (Hawkins and Gunter, 1946; Mazur and 
Bodansky, 1946), but inhibition of specific acetylcholinesterase 
by some 60 to 701,)/:, leads to acute acetylcholine poisoning, 
(Hawkins and Mendel, 194.7 and 1949; Nachmahsohn and Feld, 1947). 
Experiments have shown that there is a correlation between the 
inhibition of specific cholinesterase and the pharmacological 
effects of cholinesterase inhibitors, (Blaschko, BUlbring and 
Chou, 1949; Kordik, Btlbring and Brown, 1952). No species is 
thought to be devoid of pseudo-cholinesterase, but ruminants do 
not possess measurable quantities in their plasma (i,iendel et al, 
1943; Gunter, 1946). Hence in the in vivo experiments reported 
here in sheep and cattle it is probable that specific acetyl- 
cholinesterase was measured in each blood fraction; and in the 
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horse plasma pseudo-cholinesterase was actually encountered. 
Fleisher, Pope and Spears (1955) showed in several species that 
there was a direct relationship between inhibition of the 
erythrocytic enzyne which is the critical one, and inhibition of 
whole blood cholinesterase activity. On this evidence and in 
view of the fact that in the experiments here, there was no 
significant difference in the affinity of the inhibitor compounds 
for the two respective blood fractions, it was considered that 
whole blood estimations would yield satisfactory results and it 
should be possible to infer relative potencies of inhibitors from 
in vitro pI50 figures for whole blood haemolysates. 
Whole blood pI0 figures (using acetylcholine as substrate) 
showed a wide species variation on the anticholinesterase action 
of quinuronium and amicarbalide, whereas eserine was constant. 
Assuming that quinuronium is a competitively reversible inhibitor, 
the degree of inhibition will depend on equilibrium of both 
substrate and inhibitor with enzyme receptors, and it may' be 
possible that an inhibitor such as quinuronium has different 
equilibrium constants with the enzyne receptors of different 
species - this could produce a differential species susceptibility 
to the agent. 
An important investigation now considered was the determin- 
ation of the relationship of eserine end quinuronium with the 
substrate and enzyme. Burgen (1949) showed that the inhibitory 
power of a competitive anticholinesterase diminishes in the 
presence of increasing substrate concentration, and also that the 
enzyme itself is inhibited by excessive quantities of its own 
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substrate; substrate inhibition. In the investigations to 
determine the reversibility of winuronium, samples containing 
inhibitor were compared with similar samples containing no 
inhibitor. Thus relative enzymic activities of uninhibited and 
inhibited cholinesterase were compared at each concentration of 
acetylcholine. The relative potencies of inhibitors could be 
calculated by subtracting the activity of inhibited from 
uninhibited enzyme and expressing the difference as a percentage. 
Quinuronium was seen to be similar to eserine; i.e, subject to 
substrate reversal of activity. 
The plateau of iwhfbition over the lower range of acetyl- 
choline concentrations does not agree with the usual expotential 
curve produced by other authors (Burgen, 1959) . However it may-be 
explained by the fact that the lowest concentrations of acetyl- 
choline fall near to or above the upper limit of linearity of the 
acetylcholine - colorimeter cOibratiOn curve which may produce 
falsely low values at low Ach concentrations. 
The experiments described here showed that eserine and quinu- 
ronium were competitively reversible by acetylcholine. However 
it was not possible to give a quantitative expression by this 
method of assay. Other authors, e.g. Burgen (1949), describe 
Warburgian estimations which are suitable for the wide range of 
values involved. 
In the living sheep, cholinesterase assays following 
treatment with cholinesterase inhibitors showed that eserine had 
a marked but transient effect. Cctamethylpyrophosphoramide 
(0.Y.P.A.) had a profound action which was slow in onset:- 
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80-8% inhibition of whole blood activity occurred after a period 
of one and a half to two hours. DuBois et al (1950) ascribe 
this slowness of onset to the fact that 0.M.P.A. is metabolised 
in the liver to produce a strong anticholinesterase compound, 
as 0.11.P.A. itself is almost inactive in vitro. According to 
DuBois et al the serum of rats receiving 5 mgm O.M.P.A. per kgm 
weight did not recover enzyme activity for one week after injection. 
It was seen that sheep behaved similarly. 
Quinuronium had a marked effect on whole blood cholinesterase 
activity: inhibition was rapid in onset and prolonged. It was 
shown in vitro that quinuronium was a competitively reversible 
antagonist; nevertheless, Cernaianu et al (1935) found that sheep 
which received a second dose of quinuronium within two weeks of 
the first dose showed greater toxicity. It seemed important to 
investigate this directly and try to show whether repeated doses 
of quinuronium had a cumulative effect. It was shown that a 
second dose of quinuronium did appear to reduce enzyme activity 
to a lower level than the first dose, which would support the 
clinical observations of Cernaianu et al (1935). However, using 
only four animals the standard deviations were so large that the 
difference was not significant. Nevertheless, clinical signs of 
toxicity in these four sheep were much more marked after the 
second dose of quinuronium and it might be inferred that a more 
exact method of determining cholinesterase activity would be 
necessary to establish this particular point. A cumulative effect 
would in any event be difficult to explain in view of the evidence 
for the competitive reversible nature of quinuronium t It is 
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possible nevertheless that part of the action of quinuronium on 
cholinesterase may not be reversible or that other factors produce 
a cumulative effect which may or may not be associated with anti- 
cholinesterase activity; for instance, detoxication/excretion 
about which, as far as can be ascertained, little precise 
information is available. 
Amicarbalide had only a very slight inhibitor effect on 
circulating cholinesterase ana this would not be regarded as 
clinically significant. 
The evidence of Rummler and Laue (1961) that pyridine 
aldoxime methiodide (2.P.A.11.) significantly alleviated quinu- 
ronium poisoning could not be confirmed. 2.P.A.M. is recognised 
as an agent which protects or reactivates cholinesterase, after 
the enzyme has been inhibited by organo-phosphorus compounds, 
(Wilson and Ginsburg, 1955). Enzyme inhibition, by organo- 
phosphorus agents has been described as being the result of 
phosphorylation of active groups on the enzyme aurface, (Bergman, 
Wilson and Nachmahnsohn, 1950; Wilson, 1954; Hobbiger, 1954) 
and alleviation of toxicity isSaid to be brought about by the mime 
splitting the phosphate linkages, (Bobbiger, 1955, 1956 ex 1957; 
Hobbiger and Sadler, 1959; Rutland, 1956; Childs, Davies, Green 
and Rutland, 1955). However, the oximes will produce some 
protection and alleviation of human cholinesterase inhibited by 
quaternary ammonium compounds such as neostigmine, but not eserine, 
(Grob and Johns, 1953; Kewitz, Wilson and Nachmahnsohn, 1956). 
It must follow, therefore, that oximes reverse cholinesterase 
inhibition by means other than splitting the phosphate linkages. 
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High concentrations of 2.P.A.. have produced reversible block 
to acetylcholine in isolated frog muscle, (Fleisher, Corrigan and 
Howard, 1958) so it may be that one of the actions of oximes is 
to antagonise acetylcholine. 
In sheep 2.P.A.M. itself. showed slight inhibition of whole 
blood cholinesterase which agreed with earlier observations in 
other species (Grob, 1961). However, the oxime afforded no 
protection against the inhibitory activity of eserine, (Grob and 
Johns, 1958) or quinuronium: (in the latter case, 2.P..tt. . was 
useless prophyllactically and. therapeutically). Nevertheless, 
the oxine protected onset of inhibition by O.M.P.À.. and relieved 
inhibition during the period of depression of enzyme activity. 
Such relief was short -lived owing to the short life of 2.P.A.M. 
which has a half clearance of 0.9 hour; the molecule being 
removed by the kidney (Grob, 1961). These biochemical findings 
showed that 2.P.A.M. did not alleviate the inhibition of whole 
blood cholinesterase activity by quinuronium in sheep. The 
results however do not necessarily invalidate the clinical 
improvements reported by Ruimnler and Laue (1961) since it is 
possible that 2.P.A.M. may be acting on cholinesterases in sites 
other than blood, or may be acting in some other capacity. 
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SECTION III 
THE RELEASE OF TISSUE HISTAMINE 
'1,hile it had been shown that most of the pharmacodynamic 
activity of quinuronium was parasympathetic, it was Quite clear 
that there was some activity which could not be explained in 
these terms. This together with Kikuth's (1935) observations on 
the resemblance between quinuronium toxicity and shock, suggested 
the investigation of methods for determining the release of tissue 
histamine. 
METHODS. 
I. THE BLUE DYE TEST 
The technique was first described by McIntosh and Paton 
(1949) and improved by Miles and Miles (1952) and by Feldberg and 
Miles (1953). 
In this method a blue dye such as Evans Blue or Pontamine 
Blue is injected intravenously. The dye remains in circulation 
and does not stain the tissues appreciably. The intradermal 
injection of histamine or a histamine releaser, by increasing 
capillary permeability in the local area produces a discreet 
blue patch. Histamine releasers given intravenously produce a 
generalised blue coloration. 
(a) Guinea Pig. 
White guinea pigs were used (300 - 500 gms). Hair was 
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roughly clipped from one flank three days prior to the experiment 
and the clipped area was then depilated with barium sulphide cream. 
The flank was washed well with soapy water dried and powdered 
with talc. Three days later the animals were anaesthetised with 
urethane and fixed laterally. Each animal received Pontamine 
Sky Blue 6x (5»: aqueous solution) intravenously at the rate of 
1.3 ml per kgm. Small intradermal injections were made of 
solutions containing the stated amount of drug in 0.2 ml isotonic 
saline. In each animal 0.2 ml of isotonic saline was injected 
intradermally as a control. 
(b) Sheen, 
Sheep were clipped over the whole of the left flank, which 
was then depilated, washed and powdered with talc. 4,fter three 
days the animals were anaesthetised with thiopentone and maintained 
on closed circuit cyclopropane and oxygen. 
Intravenous Pont amine Sky Blue was given as in guinea pigs 
and drug solutions were injected intradermally. 
Druçs. Histamine; Compound 48/80; quinuronium and amicarbalide. 
2. IN VITRO PERFUSED RAT HIVD-QUARTERS 
The perfusion technique was described by Feldberg and Mongar 
(1954) and the following description is very similar. 
White female rats were killed and cut in half at the thoraco- 
lumbar junction. The body was eviscerated and duodenum and 
rectum ligated. The posterior half of the body was perfused 
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with oxygenated Krebs solution (Krebs and Henseleit, 1932), 
(pre-heated to 40°0) via the dorsal aorta, and perfusate collected 
from the caval vein, Mg. 
When the Krebs perfusate was blood-free, a control sample 
was collected over a period of twenty minutes, then perfusion was 
transferred to a second reservoir which contained a solution of the 
drug under test in Krebs solution. Perfusate from the drug 
treated tissue was collected for approximately one hour. 
Both the control sample and the 'drug' perfusate were 
treated according to the method of Feldberg and Talisnik (1953); 
i.e. hydrochloric acid (conc.) was added to the perfusion fluids 
to produce an acid concentration of 2cs y/V HC1, These mixtures 
were then boiled for ten minutes and neutralised with strong 
sodium hydroxide solution (using universal indicator paper) and 
diluted to the required volume with Tyrode solution. Histamine 
assays were performed on guinea pig ileum in atropinised Tyrode 
(1 x 10 
-8 
(. atropine) using the matching assay technique. 
To exclude any not-histamine component the solutions were 
re-assayed after the antagonism of histamine by mepyralnine maleate 
(1 x 10-7G.). 
NOTE. After completion of tissue perfusion in each case, Indian 
ink was injected into the perfusing fluid and the coloration of the 
tissue indicated the efficiency with which the perfusion had been 
carried out. In all cases recorded, this was virtually 10Co. 
Drugs. Quinuronium sulphate, 500 ug/M1; amicarbalide isethionate, 
2 mgm/ml; compound 48/80, 100 ng/ml. 
krQbs 
containin 
drug. 
APPARATUS FOR PERFUSION 
OF RAT HIND QUARTERS 
kreb, 
thermostat 
heater coil 
unit 040 °C 
thermometer 
40 °C 
perfused 
rat 
hind quarters, - 
perspe x 
t ray 
in glass funnel 
parfusato 
PIG. H.A. 
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IN VITRO RELEASE OF HISTAMIE FROM SHEEP 
DIAPBRAGM STRIPS 
The diaphragm of the rat has been used as a standard technique 
for demonstrating histamine release (Rocha e Silva and Schild, 
1949). These authors incubated hemi-diaphragms of freshly killed 
rats in saline containing potential histamine releasing agents 
and assayed both the bathing fluid and the tissue for histamine. 
Tissue: A small area of diaphragm was taken from a freshly killed 
sheep. The area chosen was at the junction of the muscular and 
tendinous portions of the organ. From the peritoneal side of 
this muscle, a thin sheet was prepared by splitting the musculature 
with a clean safety razor blade to leave the peritoneum and a thin 
layer of attached diaphr V tic muscle about 3 mm thick. This 
thin sheet was then divided into a number of strips approximately 
1 cm wide and 3 ems in length. The strips were carefully 
"washed" in warm (3700 norma saline for one minute, after which 
they were carefully dried between sheets of cellulose tissue and 
weighed. 
Sixteen such strips were prepared and each was placed in a 
tube containing 8 mls of Krebs saline (Krebs and Henseleit, 1932). 
Four tubes remained untreated as controls and the second, third and 
fourth groups of four respectively contained quinuronium, 500 mgm 
per ml; amicarbalide, 2 mgm per ml; 48/80, 100 moriper ml. 
All tubes were incubated for half-an-hour in a constant temperature 
water bath at 37°0. 
After exactly thirty minutes, the tissue was carefully removed 
from each tdbe, to each of which was added a sufficient quantity 
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of concentrated Bel (i.e. 2 ml) to make the resultant solution 
approximately 2O w/V. All tubes were heated in a boiling 
water bath for thirty minutes, then neutralised with sodium 
hydroxide solution. The volume of fluid in each tube was 
measured and its histamine content assayed as described; before 
and after mepyramine. 
4.. IN VIVO HI3T1INE RELEASE IN MICE 
Experiments were designed according to the recommendations 
of Riley (1959) for rats and mice during mast cell studies and 
investigation of histamine release. A modification of Riley's 
n sub-acute" experiment was adopted. 
The investigation involved groups of mice (six - eight) into 
which therapeutic doses of the babesicides were injected intra- 
peritoneally over a period of several days. A "standard" group 
was injected with 48/80, and another group received an equivalent 
volume of normal saline. In addition to the assay of histamine 
in the animal tissues after chemotherapy, microscopy was planned 
in order to investigate the effect of babesicidal chemotherapy on 
the mast cell population. 
Drugs.. 
(1) Cuinuronium sulphate. 
A therapeutic dose is of the order of 1 mgm per kilo. 
According to Kronfeld (1959)0 mice will not tolerate 2 mgm/kilo 
over two or three days, whereas rats may tolerate up to 
10 mgnVkilo. The following dosage routine was adopted: 
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day 1: 1 ug/Gm (-4; 1 mgm/kilo); day 2: 1.5 ug/Gm; 
day 3: 2 ug/Gm. 
(2) Amicarbalide isethionate. 
This compound is active at a dose rate of 5 mgm/kilo and is 
well tolerated in all species up to 20 mgm per kilo, (Beveridge 
et al 1960). A dose rate as high as 40 mgm/kilo is toxic but not 
lethal. On this basis the following routine was made: 
day 1: 20 ug/Gm; day 2: 25 ug/Gm; day 3: 30 ug/am. 
(3) amatind 486:19t. 
According to Riley, (1959) the dose rate approximated to 
2 mgm per kilo so the dosage routine was: day 1: 2 ug/Gm; 
day 2: 2.5 12a/Gm; day 3: 3 ug/Gm (see Table 133). 
TABLE 11,3 
SUMMARY OF DOSLGE ROUTINE IN MICE 
GROUP Da 1 DAY 2 DAY 
10.0 a.m. 10.0 a.m. 9.0 a.m. 
CONTROL 0 0 0 
QUIINURONIUM 1.0 ug/Gm 1.5 ug/tm 2.0 ug/Gm 
AMICARBALIDE 20.0 " " 25.0 " " 30.0 " " 
48/80 2.0 " " 2.5 " " 3.0 
The mice used were of mixed strains and sexes, chosen at 
random (weights varied from 20 to 4.0 grammes). On the third day 
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of injection, (three hours after the final injection), 4 mice 
from each group were killed and skinned completely, including the 
ears. A representative portion of skin was taken, chopped up 
finely, weighed and added to a small volume of 20,k, w/v BC1. 
This was then boiled gently for ten minutes and filtered through 
'sratzr)..,n No. 1 filter paper, and washed with three volumes of 
distilled water. The clear filtrate was boiled to a small volume 
and either assayed immediately (where possible) or stored deep 
frozen until convenient. (Each batch of samples was treated 
identically; either all being assayed as soon as possible after 
extraction or all being stored an equal length of time.) Before 
assay the extracts were neutralised with sodium hydroxide and 
diluted if required with Tyrode solution and assay was carried out 
as described above according to the method of Feldberg and 
Talisnik (1953). 
Histology. In addition to tissue extraction for histamine; fresh 
tissue samples of subcutaneous fascia were taken and spread thinly 
on a microscope slide for histological treatment after the method 
of Riley (1953) for investigating the mast cell population. 
Staining method. 
a. Smears fixed in 8) alcohol for 24 hours. 
b. Excess fat trimmed from smear. 
c. Immersed in xylol for 1 hour. 
d. Immersed in 80» alcohol for 1 hour. 
e. Stained with IA toluidine blue (1:4O alcohol) 
for i to 3 minutes. 
724-. 
(i) washed in wy alcohol. 
(ii) rinsed in absolute alcohol. 
(iii) cleared in xylol. 
(iv) mounted in D.P.X. medium. 
THE EFFECT ON MAST CELLS OF MASSIVE ACUTE DOSES OF COMPOUND 48/60 AND 
Further groups of six mice were taken concurrently with the 
experiment previously described, in order to investigate the effect 
of large six ga doses of quinuronium and 48/80. 
The two compounds were injected intraperitoneally, each at 
a dose rate of 5 ug per gm. Tissue spreads from the mesentery 
were fixed and stained as described previously and examined for 
mast cells. 
LE1SE IN RATS 
(See earlier note on methods in mice.) 
The experiments were repeated using white female rats. 
Coml,ound 48/80 was not included in these investigations and it 
was decided to increase slightly the dose of amicarbalide,(see 
Table 114). Histamine assay and histological examination was 
undertaken as before. 
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TABLE 1-14 
SUMMARY OF DOSAGE ROUTINE IN EATS 
GROUP DLLY 1 DAY 2 DAY 3 
CONTROL 
QUINURONIUM 
ANICARBALIDE 
10.0 a.m. 
0 . 
1.0 ug/Gm 
30.0 " " 
10.0 a.m. 
0 
1.5 ug/Gm 
35,0 e, r, 
9.0 a.m. 
-0 
2.0 ug/Gm 
40.0 
EAST CELLS OF SEFFR 
It is convenient to consider here a histological study of 
the mast cells of the same group of sheep which were used for 
recording of carotid blood pressure in Section I. 
Technioue. Sheep were anaesthetised with thiopentone and 
cyclopropane. The animals received intravenous injections of 
small quantities of histamine (100 ug), acetylcholine (100 ug), 
and adrenaline (20 ug) and in a number of injections over a period 
of one hour received a total of 150 to 200 mgms of quinuronium in 
doses ranging from 50 ug to 50 man, (see Fig. BP 4 (i) and (ii): 
SectionI.) This dose amounted to approximately five times the 
therapeutic dose spread over the one hour period. The animals 
received atropine (1 mgm per kilo) midway through the experiment 
which was designed to investigate the antagonism of atropine for 
quinuronium. Sheep which had received mepyramine as an 
TABLE H5. 
THE 17dTRAUFR+AL BLUE WHEAL TEST 
DRUG 
QUANTITY 
IN 
0.2 
SALIT; 
OBSERVATION 
HISTAMINE 
100 ug 
250 ug 
500 ug 
Blue ring - 
Blue ring - 
Intensely blue disc - 
48/80 
200 
ug 
1 mgm 
)) Blue ring - 
Intensely blue disc - 
QUINURONIUM 
500 ug 
1 mu 
5 raga 
) Bright blue 
) narrow ring - 
Intense blue band - 
AMIOARHUIDE 
1 mgm 
5 mgm 
10 mgm 
Small pale blue ring - 
Blue ring - 
Deeper blue ring -- 
SALINE 0.2 ml 
Tiny blue spot indicat- 
ing injection site 
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antagonist were not used in the present connexion owing to t1 
possible interference of this compound with histamine release, 
(Meta, 1960). After blood-pressure recording was completed the 
sheep were either killed by overdosing with cyclopropane or were 
e]ready dead. 
"Control" tissues were obtained from sheep which had been 
killed by an overdose of thiopentone sodium and into which no 
other drug had been injected. At post mortem tissue spreads 
were taken from the peritoneum. Liver capsule also was carefully 
stripped off, placed with the serosal surface on to a clean 
microscope slide and excess liver parenchyma scraped off with 
clean knife blade. Both tissues were fixed and stained ae 
described earlier for mice and rats. 
RESULTS. 
1. THE BLUE LYE TEST 
(a) Guinea Pig,. 
The drug injections and the observed effects are tabulated 
in detail in Table H5 and may be summarised:- histamine, 2+8/80, 
and quinuronium all produced a bright blue ring at the lowest 
dose level within one to two minutes, which became more intense 
and of wider diameter within the succeeding few minutes. The 
highest dose levels used produced intensely blue rings very 
rapidly indeed, which quickly spread over an area of several 
square centimetres. At post mortem the "reverse" side of the 
skin was examined and this presented a similar picture to the 
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outer surface and one could clearly make out the cutaneous 
blood vessels which had been outlined in blue also. 
Amicarbalide at its lowest level produced only a very faint 
small blue ring which was slow in appearing (five minutes). In 
higher doses a somewhat deeper ring was obtained but its formation 
was slower than that of the other drug induced rings (three to 
four minutes) and was not of the same intensity of colour. 
An equal volume of normal saline injected intradermally as 
a control in each animal produced no blue ring or wheal but merely 
a tiny blue spot which marked the site of entry of the hypodermic 
needle. 
(b) Sheep. 
From Fig. HO it can be seen that the relatively large dose 
of histamine produced the most marked response. With histamine 
an intense blue wheal appeared within half-a-minute of injection 
and spread rapidly and widely. The two histamine wheals merged 
after several minutes and yielded a large elongated blue patch of 
some six to eight square inches in area. 
Compound 48/80 produced discreet but intensely blue wheals 
of the order of one square inch area, as did quinuronium. With 
quinuronium there was a yellowish green colour at the centre of 
the wheal due to the yellow colour of the drug; and an intense 
blue could be seen at the periphery of the wheal. Amicarbalide 
at the lower dose produced only a very faint small wheal after a 
lapse of five minutes or more, whereas the larger dose yielded a 
more rapid response and a larger wheal which was not so intensely 
coloured as those due to other drugs. 
I 
I 
HIST 
j00 
9 
500 
500 
re 
25 
m9 
200 
rg 
48'80 
2.5 
:. 
PIR S AMICE 
voariormort 
F IG ìi.O. 
EXTRA.-VASCULAR Dtb'FUSIGN OF PONTAIINE 
BLUE IN THE SKIN OF SHEEP AFTER INTRADERASA.L 
INJECTIONS OF; HIST. = HISTAMINE BASE; 
48/80 = COMPOUND 48/8O; PT'i3.. = QUTNUROïdIUM 
SULPHATE "P '{"VAN"; AMIC. - AMICARBkLIIE 
Iä.C::THIONATE; SAL. = ISOTONIC SALINE, 
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TABLE 116 
CUANTITIES OF INTRADERMAL INJECTIONS IN SHEEP 
DRUG 
INTRADERMAL INJECTION 
DOSE IN 0.2 ml N SALINE 
HISLYI:INE 
48/80 
QUINURONIUM 
AMICiARBALIDE 
NORMAL SALINE 
1. 
100 ug 
200 ug 
500 ug 
500 ug 
0.2 ml 
2. 
500 ug 
1 Egm 
2.5 EgE 
2.5 EgE 
. IN VITRO PMFUSED RAT HIND PUARTERS 
Assays indicated that control samples contained no histamines 
Quinuronium and amicarbalide at their respective dose rations 
(1:4) were approximately equi-potent in releasing histamine, 
whereas compound 48/80 was about three tiEes as potent, (Fig. 111). 
(Histamine from the tissue was expressed as microgram base 
per ml. perfusate (see also Appendix Table 
IN VITRO RNTEASE OF HISTAMINE FROM 
SHEEP DIAPHRAGM STRIPS 
Figure H2 shows that an appreciable quantity of histamina 
appeared in the control tubes, however in one tube there was 
FIG. iI l. 
QUANTITY OF HISTAMINE YELEA; "a YRCPd ISOLATED 
SALINE.-PERFUSä'D HIND QUARTERS OF TEE RAT BY 4UINURONTI`i 
SULPHATE, COMPOUND 14,/80 AND AVICILRBAL:LDE ISETHTOPïA.T.E. 
'09/W7 7 VI!od'"IO0 CIq? EariVaHV+.`?ItIV glqaMHcl`Z(l.ci 
wmOuílnIIn0 ñ£I ( mïnll mi ) ?tDVaT3l7Ia. (I= do SJzxIs 
urriosx WoxJ =man 4 gn STINVIsIR Jo XI7IMM) 
'?'1./ -ma 
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virtually none (mean 1.63). This gave rise to the large standard 
error in the control reading (0.6). 
Compound 48/80 released 9.60 microgram of histamine per 
gram tissue. Quinuronium released a mean 5.62 0.66, whereas 
amicarbalide released an amount of histamine which was not 
significantly different from the controls, (see also Appendix 
Table M). 
IN VIVO RELEASE OF FaSTAEINE IN MICE 
Within five minutes of the intraperitoneal injection of 
quinuronium or compound 48/80, the mice became restless and 
showed signs of dyspnoea and cyanosis of the extremities. Mice 
which had received quinuronium were more markedly affected and 
eventually lay quite still before recovering. Over the period 
of three days the mice appeared to acquire tolerance to 44/80 
and by the third day showed little signs of distress. Mice did 
not seem to have tolerance to the action of quinuronium. The 
group of animals which received amicarbalide showed little effect 
but became slightly restless. 
(i) Histamine Assay, 
Figure I-13 shows that compound 44/80 and quinuronium reduced 
the skin histamine content by approximately 5, whereas nmi- 
carbalide failed to show any significant release of histamine. 
Repetition of the experiment on a number of occasions produced 
the same results. (See also Appendix N). 
221 1_11.11L 
TISSUE HISTAMINE CONTENT OF THE SZIN OF VICE 
IN VIVO TREATED WITH QUI.``#üRONTUi=I SULPïATE, Avila AREA- 
TALE ISETHIONESTE ADM CONFOUND 48/800 
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(ii) Bistology. 
It was thought to be fairly satisfactory to observe relative 
degrees of mast cell change rather than to make counts as 
described by Riley and West (1952 & 1953) and Riley (1953). 
Significance was taken from obvious reduction in cell numbers 
and from degranulation and metachromesia of cells. 
Photomicrographs of subcutaneous tissue stained for mast 
cells are reproduced under Appendix P. There was generally good 
qualitative correlation between the histamine content and the 
number ana character of the mast cells of the tissue. 
Normal mice (having received only isotonic saline) showed 
many mast cells of an intact dark-blue staining character. Sub- 
cutaneous tissue from quinuronium treated mice contained fewer 
mast cells which were pale-staining (metachromatic) and non- 
granular. after compound 48/80 it was difficult to find any 
intact mast cells. Anicarbalide had not altered the mast cell 
picture very markedly, but there appeared to be fewer cells in 
any field of the microscope and many of these cells seemed to be 
swollen and possibly in a state of disruption. This may or may 
not have been significant, (see Appendix PI to IV incl.). 
TEE EFFECT ON MAST CELLS OF MASSIVE ACUTE DOSES OF COMPOUND 48/80 
AND WINURONIUM. 
In all groups of mice receiving 5 microgram per gram of 
quinuronium there was usually 100A death rate, but occasionally 
one mouse out of six would survive. Symptoms were severe and 
included marked dyspnoea, bulging eyes and cyanosis with collapse 
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and death. The mice treated with compound 48/80 invariably 
survived although they showed severe toxic symptoms as above. 
Histological investigation was undertaken in four mice from each 
group of six, 
Toluidine blue stained mesentery spreads showed only a few 
intact mast cells. There had been widespread disruption of cells 
by both 48/60 and quinuronium and many blue and red staining 
granules were scattered over the whole field. (Representative 
Pictures are shown under Appendix PV a. and b.). 
0 IN VIVO HISTAM1N4 REIKASE IN RATS 
Within a few minutes of the injection of quinuronium the 
rats began to show signs of respiratory distress» frenzied move- 
ments and cyanosis. 
(i) Histamine assay. 
Figure 1-34 demonstrates that quinuronium and anicarbalide at 
these their maximum therapeutic dose rates are approximately 
equi-active in reducing the amount of tissue histamine in the 
skin of rats. 
The experiment was repeated several times and gave similar 
results: the actual figures for the first experiment are given 
in Appendix O. 
(ii) 111.151212aL 
Subcutaneous tissue spreads from rats which received only 
isotonic saline showed a population of dense dark-blue staining 
mast cells. In rats which had received quinuronium, mast cells 
FIG. H.4.. 
TISSUE FiTSTANINE CONTENT OF THE SKIN OF RATS 
(IN V0 ) TREATED WITH QüINUROTtiIUE SULPHATE AND API- 
CARBt`xLTDE ISEMIONKTE 
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were very few in number arid in some fields of the microscope 
there were scattered metachromatic granules. Amicarbalide also 
reduced the number of mast cells present and those which remained 
were either pale and non-granular or appeared to be swollen and 
possibly in a state of disruption. (See Appendix MI VII &VIII). 
MAST CELLS OF SHE 
The effects of ciuinuronium in the anaesthetised sheep were 
reported in Section I and included dyspnoea and hypotension. 
Histology. 
Peritoneum. Sheep which had received no drug other than an 
aqueous solution of thiopentone showed tissues rich in mast cells 
which were dark-blue staining. Tissues from sheep which had 
received large doses of quinuronium acutely seemed to have fewer 
mast cells present but the most obvious change was the pale 
metachromasia of the "treated" cells and the presence of meta- 
chromatic granules over the tissue preparation. 
Liver92pali12i Here quinuronium produced marked depopulation 
of tissue mast cells although metachromasia in the remaining 
cells was not marked. 
(See Appendix MI & XII). 
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DISCUSSION. 
Evidence from experiments with intravenous pontarnine blue 
and intradermal drug injections has been shown to be good though 
indirect evidence of histamine release, and has been used as e. 
screening test for histamine liberating properties of new drugs. 
In the guinea pig, (Miles and Miles, 1952), intradermal histamine 
or 48/80 did not produce a true wheal as in man. In sheep in 
the experiments described here it was possible to detect a slight 
but positive wheal although the colour reaction was the most 
obvious response. Miles and Miles (1952) also found that many 
influences modified the reaction, in particular body temperature 
and depth of anaesthesia. Although an experiment such as this 
cannot be truly quantitative and does not constitute complete 
proof that histamine is the agent responsible, it gives a good 
indirect indication of the potential histamine releasing activity 
of a drug; compound 4480, quinuronium and amicarbalide all 
produced distinct evidence of histamine release, in guinea pigs 
and sheep. 
It was clear that in order to produce rigorous proof of 
histamine release by quinuronium and amicarbalide it would be 
necessary to do direct determinations of the tissue histamine 
content before and after drug treatment. Hence the direct 
methods of assay were adopted. 
In vitro evidence from perfused rat hind quarters and 
isolated sheep diaphragm indicated that quinuronium was a potent 
histamine liberator. In the rat, amicarbalide was equi-potent 
with quinuronium, whereas in sheep diaphragm, amicarbalide had no 
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apparent action. A difficulty which arose in the sheep 
diaphragm experiments was a very high and variable spontaneous 
release of histamine. Rocha e Silva and Schild (1949) reported 
this also in rat hemi-diaphragms. These authors were incubating 
tissues- with d-tubocurerine in oxygenated Tyrode at 37°0, whereas 
in the sheep experiments described here, Krebs solution was 
unoxygenated. This May have represented a significant difference 
in technique. Other factors which may have contributed to the 
spontaneity and variability were (1) uneven thickness of the 
strips; (2) the absolute thickness, 3mm, making oxygen and 
drug diffusion less efficient; (3) trauma in the preparation of 
the samples. Nevertheless, evidence was obtained for the histamin 
releasing activity of quinuronium but not for amicarbalide. 
In vivo experiments in small rodents (rats and mice) were more 
informative. In mice, Compound 48/80 and quinuronium released 
similar quantities of histamine, and this histamine release was 
reflected in the respective degrees of mast cell degrenulation and 
disruption. Ainicarbalide failed to release any significant amount 
of histamine from mouse skin although the mast cells appeared to be 
of an abnormal character and fewer in nuMber. These findings were 
not exactly reproducible in the live rat where it was shown that 
amicarbalide and quinuronium liberated similar amounts of 
histamine and reduced the number of mast cells. The symptoms of 
toxicity in mice showed that although quinuronium and 48/80 
released similar quantities of histamine, quinuronium was 
distinctly more toxic. Also in rats where quinuronium and ami- 
carbalide were equi-active in liberating histamine, quinuronium 
produced more severe symptoms. This suggested that quinuronium 
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had toxic properties other than the release of histamine which 
is in agreement with the experimental evidence of Sections I and 
II of this thesis. 
Riley (1959) observed that in mice the skin histamine could 
not be depleted by more than 50¡ and only a proportion of sub. 
cutaneous mast cells were correspondingly affected. It would 
seem that the toxicity of 48/80 in mice is less dependent upon 
histamine release than in rats. The current experiments con- 
firmed these observations and showed that auinuronium released in 
the region of 50ïß histamine. However, the very extensive, almost 
complete destruction of mast cells seemed to be out of proportion 
to the 50°ïó histamine liberation. This discrepancy was difficult 
to explain. As Riley (1959) pointed out, not all histamine is 
held in mast cells and it does not all respond to the action of 
chemical liberators. These facts may explain this anomaly. 
:experiments in mice with large single doses of compound. 48/80 
and quinuronium showed very marked mast cell damage in the 
mesentery. There were a few intact cells which appeared to be 
swollen,and scattered around them were pale metachromatic 
granules. The patchy distribution of mast cell degranulation is 
typical of the action of 48/b0 in mice as reported by Riley (1959). 
It seems clear that there is more than one way of releasing 
histamine from the mast cell granules: chemical, electrical 
and osmotic effects are among the more obvious. Chemical 
liberation seems to be brought about by one of two means; either 
by chemical displacement of histamine from the mast cell granule 
or by destruction of the cell and liberation of granules, 
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McIntosh and Paton (199), Riley (1959). The evidence of the 
experiments reported here did not allow one to infer in which 
capacity quinuronium was acting, since the histological picture 
also depended to some extent on the dose of the chemical agent 
used. 
The observations on the acute degranulation of sheep mast 
cells are incomplete in themselves as they are not supported by 
histamine assay. They do however correlate with other results 
in sheep and rodents and add another piece of evidence on the 
histamine liberating properties of quinuroniuru. From the results 
of other experiments in this department on sheep and standard 
conditions for histamine release; and from the experiences of 
Sanford (personal communication) it appeared that the normal 
variation in sheep tissue histamine was so great as to make assays 
difficult or impossible to interpret. It was found to be 
extremely difficult to deplete sheep in viiT of histamine by 
standard methods which are employed successfully in other species; 
for example, 48/80 in rodents, (Riley, 1959) and in the dog, 
(Paton and Schachter, 1951). Sheep invariably died during the 
course of sub. -acute or acute dosage with 48/80 without showing 
any significant difference in histamine content of tissues. It 
seemed that as with mice, the toxicity of 48/80 depended more on 
some toxic factor not associated with histamine liberation. 
It is quite clear that there is a large variation in the 
response of tissue to histamine releasing chemicals even between 
closely similar species and, therefore, evidence from one cannot 
necessarily be applied directly to another species. The present 
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experiments yielded ample evidence both direct and indirect for 
the histamine releasing activity of quinuronium; especially in 
rodents, but also in sheep. Evidence for histamine release by 
amicarbalide is negative in mice, strongly positive in rats and 
positive though less significant in sheen. Only in the rat did 
histamine release seem to play a primary role in amicarbalide 
toxicity and this provided a possible explanation of the non- 
cholinergic action of amicarbalide in stimulating gastric 
secretion. 
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SUMMARY OF THE PHAREACOLYNAnC ACTIVITY 
OFu*azoN): Ix AND AMIGARBALIDE 
1. QUINURONIUM SULPHATE. 
(a) Hypotension was produced by quinuronium in rat, guinea 
pig, chicken, rabbit and sheep. In the rat this hypotension was 
antagonised by mepyramine; in rabbits only by atropine; in 
sheep partially by both atropine and mepyramine. In guinea pig 
and chicken neither antagonist was effective. 
(b) Experiments on the blood vessels of the rabbit's ear 
showed a muscarinic effect of quinuronium, whereas plethysmo- 
graphic studies on the hind-limb and small intestine of the sheep 
showed that both histaminic and muscarinic factors were involved 
in the vascular actions, with the latter predominating. 
(c) Quinuronium stimulated both the rate and amplitude of 
contraction of the isolated heart of guinea pig and rabbit. The 
effect was not muscarinic, but in the absence of a suitable 
antagonist it was not possible to determine the extent this might 
have been due to histamine or to histamine-like activity. 
The stimulant effect of quinuronium on the isolated heart suggested 
that such a cardiac action could play little part in inducing 
hypotension and it was concluded that peripheral vaso-dilatation 
was probably the more important factor. 
(d) The contractions of the smooth muscle of the intestine 
and bladder by quinuronium appeared to be muscarinic and the 
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specific potentiating effect of this agent on the action of 
acetylcholine was evidence of anticholinesterase activity. The 
findings supported clinical evidence of defaecation end 
urination produced by quinuronium and antagonised by atropine. 
(e) Excessive salivation after quinuronium appeared to be 
attributable to muscarinic effects, whereas the stimulation of 
gastric secretion by quinuronium was not entirely muscarinic. 
The potentiating action of quinuronium on acid production induced 
by acetylcholine was indicative of anticholinesterase activity. 
It was clear that part of the action of quinuronium on gastric 
acid secretion in rats was not muscarinic, but in the absence of 
antagonists of the gastric effects of histamine it was not 
possible to show whether or not this other action was histaminic. 
(f) Small doses of quinuronium potentiated the contraction 
of supra-maximally stimulated skeletal muscle in chicken and 
rabbit, whereas larger doses produced a neuromuscular block 
apparently similar to that produced by d-tubocurarine. The 
effect of quinuronium in depressing respiration in these species 
was much greater than that of d-tubocurarine at doses which were 
equi-potent in producing neuromuscular block. This sugnested 
that respiratory depression of quinuronium was only partially 
accounted for by neuromuscular blockade. 
(g) Anticholinesterase activity was shown in whole blood 
in vitro in a wide variety of species and was confirmed in the live 
sheep. There was evidence of substrate reversal of the action of 
quinuronium in vitro, whereas in the living sheep the cholinesteras 
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enzyme did not return to completely normal activity for two weeks, 
which suggested a partial irreversibility. Sheep were hyper- 
susceptible to a second dose of quinuronium when this was given 
within two weeks of the first dose. A number of explanations 
were proposed. Studies with the cholinesterase "reactivator" 
pyridine 2-aldoxime methiodide indicated that this agent did not 
protect or alleviate whole blood cholinesterase inhibition by 
quinuronium. 
(h) Quinuronium was shown to liberate histamine from rat 
skin in vitro and from the skin of rats and mice in vivo. In the 
rat the evidence for histamina-induced hypotension and gastric 
acid secretion was substantiated by direct evidence for histamine 
release; and it seemed that released histamine was at least as 
important as muscarinic activity in this species. Direct 
evidence of histamine release from sheep diaphragm in vitro and 
indirect evidence from increased capillary permeability ("bluedye" 
test) and from mast cell disruption and degranulation indicate 
that histamine release is an important part in the overall 
pharmacodynamic activity of quinuronium in sheep. 
2. AMICARBALIDE. 
(a) Experiments with the isolated rabbit ear showed that 
amicarbalide antagonised the action of acetylcholine on the blood 
vessels. 
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(b) Further evidence of an atropine like action was obtained 
from studies on the smooth muscle of the bladder and intestine. 
(c) Amicarbalide stimulated the secretion of gastric acid in 
the anaesthetised rat and neither atropine nor repyramine antago- 
nised this. Amicarbalide partially antagonised the action of 
acetylcholine on gastric acid secretion which was further evidence 
of an atropine like action. 
(d) The anticholinesterase activity of amicarbalide was 
weak by comparison with quinuronium. This result was probably 
not clinically significant. 
(e) The release of histamine by amicarbalide was most marked 
in rat tissue, absent in mice and weak in sheep in vitro and 
in vivo. The evidence suggests that in the rat, histamine 
release is a major factor in the toxicity of amicarbalide and 
in the sheep, histamine release is positive but of less 
significance. 
N, 
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IN VITRO COMPARISON OF PER CENT INACTIVATION OF WHOLE BLOOD 
CHOLINESTERASE AFTER INCUBATION WITH INHIBITOR COMPOUNDS. 
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RESIDUAL CHOLINESTERASE ACTIVITY OF WHOLE BLOOD OF 
ATROPINISED (AT:1mg'kg) SHEEP AFTER SUB /CUT. INJECTION OF 
QUINURONIUM (Q;30 mg) REPEATED AFTER TWO WEEKS. 
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:PPE.r.:DIX L. 
THE RELEASE OF HISTAMINE FROM 
i E.F:FUSED RAT BIND-QUARTERS 
DRUG 
MEAN HISTAMINE 
RELEASE (ug/m1) 
t S.E.. 
_UINUROZIUM 1.01 
± 
0.40 (4) 
500 ug per m1 
48/80 %.Jb ± 0.32 (4) 
100 ug per na 
A1V1ICAR3LLIDE, 1.25 
± 
0.26 (4) 
2mg.m per ml 
Number of samples is in parenthesis. 
APPENDIX M. 
THE RELEASE OF HISTAMINE FROM SHEEP 
DIAPHRAGM IN VITRO 
DRUG 
TREATMENT 
uda 
DOSE 
MEAN HISTAMINE 
RELEASE (ug/tm ± S.E.) 
NONE 
= CONTROL 0 1.63 -1 0.60 (4) 
QUINURONIUM 500 5.62 - 0.66 (4) 
ilviaCAREALILE 2000 3.11 I 0.44 (4) 
+ 
48/80 100 9.60 -- 1.45 (4) 
Number of samples is in parenthesis. 
APPENDIX N. 
THE RELEASE OF TISSUE HISTAMINE 
FROM MICE IN VIVO 
DRUG 
TISSUE (SKIN) 
HISUI+;INE (ug/Gm) 
MEAN t S.E. 
NM (CONTROL) 26. 1 + 2.27 (4) 
QUINURONIUM 24. 1 m 1.65 (4) 
AYiTCARBALIDE 27.35 m 1.25 (1+) 
COTO. 14.8/80 12.31 m 1. 9 (14-) 
Nunber of animals is shown in parenthesis. 
APPENDIX O. 
THE RELEASE OF TISSUE HIST DYNE 
FROM RATS IN VIVO 
DRUG 
TISSUE (SKIN) 
HISTE,PaNE ( ug/Gm) 
hEAN i S.E. 
NONE (CONTROL) 
QUINURONIUM 
aICAFìB!'-,LLTPE 
31,4 ± 2.4 (4) 
16.1 I 37.6 (4) 
21.0 d 2.0 (4) 
Number of animals is shown in parenthesis. 
APPENDIX P 
Under appendix P are representative histological 
preparations stained by toluidine blue from mice, rats and 
sheep which show the effects on mast cells of compound 44/60, 
quinuronium sulphate and amica.rbalide isethionate. 
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FIG. P.2. 
SUB-CUTANEOUS TISSUE OF MOUSE TREATED 
FOR THE DAYS WITH QUINURONIUM. 
FIG. P.3* 
SUB,-OUTZEOUS TISSUE OF MOUSE TREATED 
FOR THREE DAYS WITH COMP. 44/80. 
x210 
FIG. P.4. 
SUB.CUTABEOUS TISSUE OF MOUSE TREATED 
FOR THREE DAYS WITH IMCARBaIDE. 
FIG. P.Q (a). 
MESENTERY OF MOUSE WHICH HAD RECEIVED 
ONE LETHAL DOSE OF QUINURONIUM, 
FIG. 112L, 
OF MOUSE WHICH HAD RECEIVED 
ONE LARGE DOSE OF 4/80. 
x24-0 
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SUB-CUTIS OF RAT TREATKO WITH QUINU- 
RONIUM FOR THREE LAYS, 
RTC " Áe Co 
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SUB-CUTIS OF RAT TREATED WITH .0a- 
CARaLLIDE FOR THREE DAYS. 
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FIG. P.9. 
FERITONEDM OF S1-2,E10 KITTFD BY 
TEIGEENTONE. 
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x 8 SO 
`FIG. P.10. 
PERITONEUM OF SHEEP KILLT,'Z) BY QUM- 
RONIUM.. 

